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Diagnostic testing for genetic disorders or techniques such as preimplantation genetic diagnosis 
(PGD) both require accurate PCR genotyping (1). The failure of amplification of one allele, 
referred to as allelic drop-out (ADO) can confound genotyping results by falsely identifying 
heterozygotes as homozygous (2). A unique ADO mechanism has previously been 
demonstrated to occur consistently in the imprinted MEST gene, where both DNA methylation 
and G-quadruplex (G4) DNA structure contributed to allele loss (3). G4s are alternative DNA 
structures that form in G-rich regions due to the self-associating ability of guanine. Under 
certain ionic conditions, four guanine residues bind together either within or between strands 
to form a G-quartet, which can then stack upon one another to form the higher order structure.  
Such structures have the ability to act as a steric block to Taq polymerase. This effect is 
exacerbated when the G4 is methylated due to an increased thermal stability (4).  
This thesis explored the hypothesis that ADO via this mechanism occurs more widely 
throughout the imprinted genome. To test this, 22 target loci containing G4-DNA motifs were 
selected from 16 imprinted genes and an assay designed to detect ADO during PCR was 
developed.  This required the creation of two variant alleles via the introduction of a single 
nucleotide polymorphism (SNP) with differential primer design. Both variants were then 
subjected to in vitro methylation and template mixing PCR experiments followed by Sanger 
sequencing to reveal mono-allelic or bi-allelic amplification. Of the 22 amplicons initially 
selected, only 14 were able to be consistently amplified and were thus used for this analysis. 
This method revealed that MEST is not alone in being susceptible to ADO events, with nine 
other amplicons showing either complete or partial mono-allelic amplification when 
methylated G4s were present. To confirm that the predicted G4 motifs did adopt the structure, 
CD spectroscopy was used. This revealed that these motifs were capable of forming the 
secondary structure and therefore contributing to ADO events. This work confirms that the 
effect of cytosine methylation and G4 regions on ADO that was previously observed (3) occurs 
more widely throughout the imprinted genome, and further highlights the need for diligence in 
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both a diagnostic and research setting when analysing imprinted genes or other methylated 
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1.1  DNA Structure  
There is no argument among geneticists worldwide that the DNA structure proposed by Watson 
& Crick (1953) represents the canonical form found within organisms. This right handed double 
helical duplex (5, 6) (B-DNA) has led to the current fundamental understanding of genetics. 
There is also no denying that the highly polymorphic nature of DNA (7, 8) enables multiple 
alternative DNA structures to be adopted (7, 9-11). These non-B DNA conformations may arise 
through particular repeating sequence motifs (7-11) or protein interactions (7, 10); however, 
secondary structures may also be a function of physiological conditions, topology and 
methylation (7). Early confirmation of these structures came through in vitro biophysical or 
molecular procedures including nuclear magnetic resonance (NMR), electrophoresis, nuclease 
cleavage, various microscopy techniques and crystallography (11, 12). Circular dichroism 
spectroscopy also played a crucial role in the majority of secondary DNA structure discoveries 
(13). Whilst these first discoveries were in vitro, there has been an increase in presented 
evidence confirming the formation of such structures under physiological conditions (10). 
However this formation is speculated to be transient and to only occur during replication, 
transcription or repair (11) when the DNA is single stranded; therefore allowing alternate forms 
to assemble.  A portion of these conformations are also known to be biologically relevant 
during DNA replication, transcription, chromosomal end maintenance (7, 9, 11) and genomic 
instability (9, 11). Well characterized non-B DNA forms include Z-DNA or left handed duplex, 
triplex DNA, cruciform hairpin DNA, looped out slipped DNA and G-quadruplex DNA (G4) (7, 8, 
11). It is the latter secondary structure that the following review will concern.  
1.1.1   Historical Background 
Identification of G-quadruplexes began with the observation that high concentrations of 
guanylic acid spontaneously formed a gel (14) which suggested the establishment of higher 
order structures within guanine (G) rich DNA sequences (10). The structure of the gel was 
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deduced using X-ray diffraction in 1962, revealing the tetrameric organisation of the guanine 
residues (14) in a rotationally symmetric fashion (15) . At this stage the self-assembly of guanine 
was still considered more of an annoyance or curiosity within a laboratory setting rather than of 
biological interest (16).  It took a further two decades before the discovery of G4s in telomeric 
DNA (17, 18) and immunoglobulin switch regions (18). It was only after these findings that the 
scientific community began to realise the biological potential of these structures.  
1.1.2   G-quadruplexes 
Guanine is one of the four building blocks of DNA and RNA; a purine nucleobase which 
predominantly binds to the pyrimidine cytosine (C) by three hydrogen bonds, as seen in Figure 
1. This Watson-Crick binding is not absolute and variations do exist. The rotation of a purine 
nucleoside around the glycosidic bond enables Hoogsteen bonds in both syn and anti syn 
orientations (19). This alternative base pairing allows for more variation within the DNA 
structure itself.  G4s are secondary DNA structures that form due to the unique ability of four 
guanines to self-associate via two hydrogen bonds per base, giving a stable square planar 
arrangement (3, 17, 18), known as a G-quartet (Figure 2A). Multiple G-quartets are then able to 
stack upon one another to form the G4 structure (Figure 2B). G-quartets are connected by 
single stranded loop of nucleic acid which does not contribute towards G4 bond formation (16). 
The lengths of the loops are in part responsible for the overall stability of the structure as 
smaller loops give stronger G4s (6, 20). Each G-quartet is further stabilised by the presence of a 
monovalent cation such as potassium or sodium taking up position in the central cavity (Figure 
2A) (12). This stabilisation is expected to be the result of neutralisation of the electrostatic 
repulsion caused by the inner guanine oxygen molecules within the central pocket (10). It 
should also be noted that G4 formation is not limited to DNA, with many biologically important 
RNA molecules containing G4 structures (21).  
Topological diversity is a characteristic associated with G4s and adds intrigue and further 
specificity into the study of such structures as targets in regards to drug development (22). 
Depending on whether a G4 consists of one or multiple DNA or RNA molecules, it can be 
classed as either intramolecular or intermolecular (Figure 2B) (16). However, G4s are further 
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characterised by strand orientation, the number of stacked G-quartets and loop length (16). 
The orientation of adjacent strands in a quadruplex determines the structural polarity, where 
all strands pointing in a common direction is referred to as parallel orientation (23). This level of 
diversity is unmatched in B-DNA as the complementary nature of this form gives predictability 
and consistency.  
The suspected transient nature of secondary structures requires the formation of G4 DNA to be 
dependent upon the denaturation of the double stranded duplex (24). A component specific to 
G4 formation however, is a nucleic acid sequence rich in repeating guanine bases (25-27). A 
quadruplex motif consists of four runs of at least three guanines, where each run is separated 
by other nucleotides (24). Once the generalised motif was determined, simple algorithms to 
predict G4 motifs were developed (25-27). This resulted in over 375,000 distinct G4 sites being 
identified in the human genome (25). This value only indicates the number of sites within the 
genome that have been predicted to have potential G4 forming ability based on sequence 
alone. However, computational algorithms do not consider non-consensus sequences forming a 
G4 and are therefore likely to be oversimplifications (28, 29). A recent study demonstrated that 
this figure is likely to be significantly greater by identifying 716,310 distinct G4 structures within 
the human genome using  a novel method called G4-seq (29). This sequencing method involves 
aspects of both polymerase stop assay and Illumina next-generation sequencing, allowing for 
the identification of over 450,000 G4 structures that had been previously unpredicted by 
computational algorithms (29).  Genome wide analyses revealed the non-random distribution 
of these potential G4 motifs, with over-representation in areas such as telomeres, 





Figure 1 Guanine and cytosine nucleotides forming a Watson-Crick bond.  
Guanine (left) can bind to cytosine (right) through three hydrogen bonds represented by 





Figure 2 G4 formation and structure.  
A) Chemical structure of G-quartet shown in a stable square planar arrangement. G-quartets 
then stack upon one another to form higher order structure. B) Various topologies of G4 
structures, either as intramolecular or intermolecular and parallel or antiparallel structures. 
Arrows indicate strand direction. Reproduced with permission from publisher Oxford University 
Press (28).  
1.1.3   Structural Analysis of G-quadruplex 
Often variation in DNA conformations can only be elucidated by structural analysis. Circular 
dichroism (CD) spectroscopy is one method that has been widely used to analyse DNA structure 
and enables the investigation of conformation and thermal stability in response to ligand 
binding, chemical modification and cationic conditions (13, 31, 32). This method incorporates 
the interactions of chiral molecules with circularly polarised light (13).  CD is the difference that 
chiral molecules have in the ability to absorb either left or right handed circularly polarised light 
(13, 33) and can be used to discriminate between structural features of a molecule. CD is 
measured over a range of wavelengths and commonly quantified in ellipticity which is 
6 
 
expressed as a function of degrees (13). This spectroscopic technique enables inferences to be 
made on G4 topology by assessing the spectral profiles (31).  
There are two main categories of G4 topology (ref 1.1.2); parallel and antiparallel, and these 
can be distinguished by characteristic spectra. Parallel quadruplexes consist of nucleotides 
arranged in anti-orientation (32)  and are represented by a distinctive peak at 260 nm (13, 31, 
32). Conversely, antiparallel quadruplexes contain nucleotides both in anti and syn 
conformations (32) and are represented by a positive maximum near 290 nm (13, 31, 32). While 
both parallel and antiparallel G4 structures are constructed from the same G-quartet building 
blocks, the stacking interactions of the guanine nucleotides around the glycosidic bond account 
for the differences in the CD spectra of the two structures (13).  
1.2   G-quadruplexes in Biology 
Review of the literature reveals a clear but gradual acceptance of the ability G4s have to not 
only form in vivo, but to also function in vivo. An initial scepticism that surrounded the 
occurrence of G4s in vivo (34) is progressively diminishing alongside the reduction in the gap 
between large quantities of in vitro data and the limited results outlining the occurrence of G4-
DNA within cells (10, 34). The readiness with which the G4 structure formed in vitro was the 
primary argument that the same could be observed in vivo (24) but debate existed over the 
apparent lack of direct experimental data available to accurately establish presence and 
function (35). However, after recent identification of G4 motif conservation spanning one 
billion years of evolution (36), ligand and protein specificity towards G4s (36-39) and most 
compelling, the visualisation of G4-DNA within cells using antibodies (37, 40)  little doubt 
remains (41) 
1.2.1   Functional Role of Quadruplexes 
Both the non-random localisation of potential G4 motifs at functional genomic regions (Figure 
3) and the fact that these sequences are conserved and therefore retained within the human 
genome at these functional regions (28, 30)  first suggested the structures have functional 
biological implications. This was followed by many justified hypotheses, where some were later 
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supported with convincing evidence that associates G4-DNA with a range of functions in the 
genome. For instance, G4s have been implicated in DNA replication, telomere maintenance, 
transcription and translation, recombination, epigenetic instability and transcript processing 
(Figure 3) (12, 22). Essentially G4s have been associated in genetic processes throughout the 
cell (Figure 3). However, it is yet to be established if all or just a subset of  the 716,310 currently 





Figure 3 G4 structures throughout the cell.  
G4 structures can form in the nucleus when the DNA is transiently single stranded during A) 
transcription B) in the single stranded telomeric DNA or C) replication. RNA molecules in the 
cytoplasm are also subjected to G4 formations which are subsequently involved in D) 
translational regulation. Red bars indicate inhibition. Reproduced with permission from 
publisher Oxford University Press (28).  
 
As mentioned, the interest in G4-DNA began after the identification of G4-DNA motifs within 
telomeric DNA; thus interpretation of the biological consequence that G4-DNA imparted onto 
the telomere gathered much scientific attention. In linear chromosomes, it is fundamental to be 
able to differentiate between chromosome ends and double stranded breaks in the DNA (15). 
This function is provided by telomeres and they also prevent chromosomal degradation (42). 
Telomeres are nucleoprotein complexes that are found at the terminal end of eukaryotic linear 
chromosomes (35, 42). They consist of both repeating double stranded sequences and a single 
stranded G-rich 3’ overhang (15, 22, 24, 42) which is the ideal substrate for G4 formation. 
Telomerase is the enzyme that resolves the end replication problem of linear chromosomes as 
it contains an RNA template that is used to extend the telomere (43). Shortening of telomeres is 
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a signal for DNA damage response mechanisms and is why overexpression of telomerase is 
observed in ~80% of cancer cells and results in uncontrolled growth (44, 45).  It has been 
suggested that G4-DNA regulates telomerase extension by blocking enzyme progression (24) 
which has led to the inspiration for G4-DNA cancer therapeutic drug developments (46). Also as 
G4s are resistant to exonuclease activity, those telomeres that have a protein cap absent may 
receive added protection and stability from the G4-DNA (22).  
It has been found that G4-DNA motifs can have a large impact on gene regulation, which was 
unsurprising due to the high density of G4 motifs discovered in promoter regions. A seminal 
study into the association between G4-DNA and promoter regions by Huppert & 
Balasubramanian (2007) illustrated strong support for the initial hypothesis of G4 structure 
having a regulatory function. This study used computational analyses to demonstrate that 1 kb 
upstream of the transcription start site (TSS) of genes are enriched in G4 motifs compared to 
the rest of the genome (47). This suggests an evolutionary selection pressure to accumulate G4 
motifs in proximity to the TSS, within the promoter region of genes (47). G4 motif density is also 
correlated to gene function (29, 47, 48). Tumour suppressor and proto-oncogenes are the most 
notable; where proto-oncogenes are more likely than average to contain a potential G4 forming 
motif (29, 47-49). Conversely, G4 motifs within tumour suppressor genes are underrepresented 
in the genome, suggesting a negative selection on G4 formation (29, 47-49). Eddy & Maizels 
(2006) proposed that such a selection pressure that could lead to differential G4 density 
between genes could be the relationship between G4-DNA and genomic instability. Unresolved 
secondary structures that lead to replication fork stoppage can result in genomic instability or 
loss of function (11, 49-51). Therefore, low G4 density in tumour suppressor genes may be an 
evolutionary adaptation to minimise genomic instability of genes which function to protect 
genomic stability (48). This thinking also holds for proto-oncogenes where G4 induced genomic 
instability would be favoured (48).  
 The proposed mechanisms of transcriptional regulation by G4s can be explained best by a 
model presented by Huppert (2008) and further illustrated in Figure 4. This model describes 
equilibrium between canonical double helical DNA with normal transcription and G4-DNA. A G4 
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binding ligand or protein would be able to generate a shift in the equilibrium towards the 
formation of G4 structure, which could then act as a steric block to transcription (Figure 4A) 
(10, 15, 23, 52). Similarly, the G4 can actively recruit proteins that can repress transcription 
(Figure 4D) (52). These can be categorised as negative regulation of gene transcription (Figure 
4A and Figure 4D). Positive regulation is possible and is illustrated with a similar mechanism; 
formation of G4-DNA on the non-template strand allows for the template to be kept single 
stranded and remain in such configuration (Figure 4B) (10). Proteins that act as enhancers to 





Figure 4 G4 and transcription.   
A) G4 acting as a steric block to inhibit transcription progression. B) G4 aiding in transcription by 
rendering template strand as single stranded. C) G4 recruiting proteins to activate transcription 
machinery. D) Recruitment of transcriptional repression proteins by G4 structure. Reproduced 
with permission from publisher Nature Reviews Genetics (10).  
1.2.2   G-quadruplexes in DNA Replication 
The methodology employed by DNA replication machinery results in the separation of the 
double strand DNA duplex, which coincidently promotes the opportunity for G4 formation, as 
illustrated in Figure 5. In particular, the discontinuous and transient nature of replicating the 







slowed (10). The higher prevalence of G4s during DNA replication was confirmed through 
antibody visualisation, revealing a maximal number of G4s during S phase (37). The highly 
stable thermodynamic properties of G4s mean they present as a formidable obstacle to 
replication machinery (Figure 5A) (41). It is clear that the presence of such a secondary 
structure can cause replication fork stalling thereby increasing genome instability (36, 38, 53). 
This stalling is directly related to the inability of a polymerase enzyme to bypass the secondary 
structure (Figure 5A) and the most comprehensive analysis of such interaction was by Edwards 
et al. (2014) (53). This study investigated the effect that an intramolecular G4 positioned on the 
coding strand would have on a range of DNA polymerases, including replicative and translesion 
polymerases. The latter are polymerases with the specific role of synthesising bulky DNA lesions 
and structures and are recruited to sites of DNA replication blockage (53). Using an in vitro 
assay, the authors observed a wide variety of enzymes experiencing stalling in close proximity 
to the G4 site, including translesion polymerases. Whilst a clear interaction between G4-DNA 
and replication stalling was observed, the in vitro design cannot rule out the potential for 
proteins within a cell to affect the stability of the G4 and therefore relieve the stalling effect 
(53). However, such results do suggest the requirement for supplementary proteins to be 
present to unwind such secondary structures during replication (Figure 5B). G4-DNA specific 
helicases have been identified (36, 38) that selectively bind to and unwind G4 structures (41). 
Persuasive experimental data exists for the necessity of specific helicase activity; for instance 
when a fission yeast helicase Pfh1 was depleted, replication forks that stalled due to a G4-DNA 
structure were more likely to lead to DNA damage (36).  
Genome wide analyses of both mouse and human genomes have found that 80-90% of 
replication origins contain a potential G4 forming motif (54, 55). Not only can the consensus G4 
forming DNA motif be used as a predictor for replication origin position (54), but has also been 
shown that these motifs are required for replication initiation (55). Using two model vertebrate 
origins, Valton et al. (2014) demonstrated that the orientation of the G4 determined the 
position of the replication start site, as replication initiation would occur 3’ to the G4 structure 
(55). The details of this process are still unknown, with many hypotheses circulating amongst 
the literature (55).  The most experimentally supported hypothesis is that single stranded DNA 
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formation caused by a cooperating cis element may allow the G4 to form and thus able to 
recruit the pre-replication complex (55, 56). The experimental support comes from the 
preferential binding of the pre-replication complex to G4 structure in both single-stranded DNA 





Figure 5 G4 in DNA replication.  
Transient single stranded DNA formed during replication can form G4 structures and A) act as 
an obstacle to DNA Pol but B) helicases that are specific to resolving G4s allow replication to 
progress. Reproduced with permission from publisher Oxford University Press (28).  
1.2.3   G-quadruplexes in Disease 
A handful of human genetic diseases have been attributed to telomeric defects and with the 
confirmation of G4s at chromosome terminals (37), it is thought likely that G4s have a role in 
telomeric stability (17, 18, 35). This hypothesis is further supported as helicases specific to G4-
DNA are often defective in such diseases (22, 24, 35, 41, 57). Helicases of the family RecQ such 
as the human WRN helicase have a high affinity and ability to unwind secondary G4 structure, 
and deficiencies in WRN are characteristic of the Werner syndrome (22, 24, 35, 41, 57). Due to 
a range of cell types being affected by this syndrome, a housekeeping dysfunction like telomere 
instability is more probable (58). Werner syndrome is an autosomal recessive disease of 
chromosomal instability; essentially a premature aging disorder with symptoms including 
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cancer, cardiovascular disease, osteoporosis and diabetes mellitus (35, 57). In human cells 
deficient in WRN helicase, telomeric sequence is lost due to the decreased ability for DNA 
replication in the 3’ G-rich tail (24). This is a direct consequence of G4 structures not being 
resolved and therefore being present during DNA replication; this is thought to be the basis for 
the connection between G4-DNA and diseases related to premature aging and genomic 
instability (24). Evidence of a G4-DNA link to premature aging disorders also exists in the finding 
that Werner syndrome cells advance through S phase during replication more slowly than wild-
type counter parts (57) which is not surprising as G4s are more prominent during this phase. 
One of the first in vivo analyses that hinted towards the role that G4s may have in Werner 
syndrome was an elegant study by Crabbe et al. (2004). This work demonstrated that cells that 
lacked WRN activity experienced deletion of telomeres and that the prevention of loss was 
dependent upon the WRN helicase activity (58). This evidence led to the reasonable speculation 
that WRN helicase is necessary to prevent telomere dysfunction and instability due to the 
nature of G-rich sequences (58).  
Two other classes of human disease have been associated with G4-DNA where the physiological 
role of G4 structure is changed in a diseased state (59). The first category of human disease 
includes cancers which typically results from or are heavily linked to a variety of genetic 
mutations, ranging from point mutations to chromosomal translocations (60). Of these 
mutations, chromosomal translocations are considered a genetic trademark of many cancers, 
especially haematopoietic cancers (60). A genetic translocation can occur at fragile spots in the 
genome that are vulnerable to breakage. Katapadi et al. (2012) demonstrated a significant 
correlation between G4-DNA motifs and fragile regions in 70% of genes where chromosomal 
rearrangements had been linked to lymphoid cancers (60).  
Neurological disorders are the second class of human disease that has been linked to G4-DNA. 
Frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and fragile X syndrome are 
part of a handful of neurological diseases where G4-DNA has been implicated. There are two 
separate pathways for which G4-DNA can alter diseased state in neurological disorders; G-rich 
sequence expansions which form G4-DNA or mutations of G4 binding proteins (59). The first 
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pathway is the mechanism for FTD and ALS and involves the repeat expansion of the noncoding 
GGGCC hexanucleotide repeat in the C9orf72 gene (59, 61, 62). Unaffected individuals carry 
less than 30 repeats (61) with an average of two (59), compared to FTD/ALS patients who 
harbour 700-1600 repeats (61). Stable RNA G4s are able to form from these repeating units (62) 
and it is thought that G4-RNA interactions can lead to transcript aggregation in FTD/ALS 
diseased states (63). The second pathway where G4 associated proteins are mutated can be 
best characterised by fragile X syndrome (FXS) (59). Expression of the G4 binding protein Fragile 
X Mental Retardation protein (FMRP) is often lacking in FXS patients (64, 65). FMRP is an mRNA 
binding protein that suppresses translation of a subset of mRNAs in the brain (66). Specific 
secondary structures are recognised in the target mRNA by FMRP, where the most common is 
G4 structure (65). When a mutation in the genetic sequence of the FMRP gene leads to a lack of 
FMRP expression, mGluR-mediated Long Term Depression signalling activity is amplified causing 
a reduction in the ability of the synapse to strengthen or weaken over time (59, 67). This form 
of dysregulation is the major basis to the diversity of FXS cognitive impairments (59, 68).  
1.3   Polymerase Chain Reaction 
Polymerase chain reaction (PCR) technology has been and currently remains of crucial value, 
and is an indispensable method in molecular genetics. PCR is an automated in vitro technique 
for enzymatic DNA amplification (69). The importance of the technique is in the ability to 
amplify intact or fragmented DNA without a pure sample (70). The PCR method is centred on 
repeated cycling of three steps controlled by temperature; denaturation of double strand 
duplex, primer annealing followed by primer extension and thus amplification with successive 
cycles (Figure 6 and Figure 7) (69, 70). Such controlled cycling allows for the desired DNA region 
to be exponentially copied (Figure 7). For instance, after 35 PCR cycles, over 68 billion copies of 
PCR product are expected (Figure 7), but reagents may become depleted after many successive 
cycles and therefore this number may not be reached. Initially an E. coli DNA polymerase was 
used for PCR amplification but this needed to be replenished after each cycle due to the 
enzyme undergoing inactivation during denaturation steps (71). The exchange of this enzyme to 
the more thermostable Taq polymerase from Thermus aquaticus allowed for the current 
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automated PCR process (71).  Amplification of DNA by this  method is usually a prerequisite for 
any experimental design that incorporates DNA sequencing, cloning, detection and genotyping 
(72); in fact, PCR is useful in any analysis that involves DNA examination (70). Such analyses are 
important in microbiological and molecular diagnostics; in particular prenatal diagnoses, 
pathogen identification, genetic association and epidemiologic studies, and determination of 
allele frequencies (72, 73). PCR is of enormous value with widespread application in genetics 
and medicine, but there are pitfalls with the method that can be overlooked and therefore 
results misinterpreted. Due to this heavy reliance on PCR techniques, analytical accuracy needs 
to be maximised and this depends on restricting genotyping errors to a minimum (1).  With 
genetically inherited diseases usually only being tested once in a lifetime, the need for a high 
level of sensitivity and accuracy is exacerbated (1). Genotyping errors can result from the loss of 
allele amplification, also known as allelic drop-out (ADO), and a range of factors may be 




Figure 6 Primer annealing during PCR.  
Double stranded DNA is heat denatured, followed by a subsequent change in temperature to 
allow for the forward primer (dark blue), and the reverse primer (light blue) to anneal. 
Polymerase enzyme is then able to extend from the primers, represented by the red arrow. 
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Figure 7 Exponential increase in desired PCR product.  
Green lines represent DNA target and the grey represents the flanking regions that surround 
the product. After four cycles it is expected that there will be 32 amplicons of the PCR product. 
PCR protocol is often around 30-35 cycles, therefore over 68 billion amplicons would be 
predicted.  
1.4   Allelic drop-out 
1.4.1   Background and Implications 
All PCRs are vulnerable to ADO (74), especially when using minute DNA concentrations (2). 
Allelic drop-out (ADO) can be described as a phenomenon where only one of the two alleles 
present in a cell is amplified during PCR; thus showing heterozygous cells falsely as 
homozygous, potentially leading to erroneous conclusions including misdiagnoses (2, 74-77). 
These events are in vitro artefacts and therefore do not impart any biological impact onto the 
cell; however, in a research or clinical setting unknown inaccuracies could be costly. In fact, any 
analysis that requires PCR has the potential to be imprecisely determined.  
1.4.2   Causes of Allelic drop-out  
There are a number of mechanisms that can contribute to ADO and these can generally be 
categorised as either simple or complex. In respect of potential causes of genotyping errors, the 
literature is weighted predominantly towards the more obvious simple causes such as 
repeating sequences, low DNA concentrations and poor DNA quality (72). However of these, 
there are only a few investigations that have analysed potential factors that lead to ADO in 
substantial detail; the most extensive survey being that of Piyamongkol et al. (2003). The 
sophisticated design of this study allowed for the discrimination between significant factors 
that affect ADO (2). Factors tested included freezing and thawing, DNA quantity, DNA 
degradation, PCR cycling conditions, DNA sequence, fragment length and cell type  (2). 
Evaluation of these elements was achieved by performing single cell PCR on known 
heterozygotes in one or more of seven sites and each factor was tested and compared to a 
positive control (2). The level of control was maintained in part due to the use of identical cells 
and methods, therefore making obvious the cause of any observed ADO. Factors that were 
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attributed to be significant in the causation of ADO were DNA degradation, freezing and 
thawing, DNA quantity, amplicon size and PCR cycling conditions (2, 74). DNA degradation is 
one of the most obvious explanations for ADO phenomena as a break in the DNA located 
between the primers would result in a lack of amplification (2, 78), however this is more of an 
issue with single cell PCR rather than when using larger amounts of DNA. Freezing and thawing 
of the cell sample is suggested to be both able to reduce and promote ADO. Firstly, the cell 
membrane can become compromised which may increase DNA availability thereby improving 
DNA access, however both freezing and thawing may contribute to DNA damage (2).  
The above sources of ADO relate to reaction conditions, but ADO can be due to more intricate 
and less obvious reasons. The literature is limited in the investigation of more complex 
mechanisms such as the role that secondary structures like G4s have in ADO or the effects of 
SNPs located in primer binding regions. A SNP that is located within the primer binding site can 
lead to a failure of annealing between the primer and target which would subsequently lead to 
ADO events (1, 69, 79, 80). Because this is not related to the reaction conditions and generally 
only one primer pair is used for amplification, a false homozygous result could be unknowingly 
accepted, which can be a significant problem in PCR analysis (79).  
Literature on the role that secondary DNA structures play in ADO during PCR is inadequate 
given the diagnostic implications that may follow. The first demonstration that G4s can 
influence PCR amplification came from Boan et al. (2004). Here it was discovered that the 
formation of a secondary structure in the human microsatellite MsH43 caused preferential 
allelic amplification (75). This effect was accredited to the ability of the G4 to interfere with 
DNA elongation of the allele containing the structure, therein generating a biased amplification 
of one of the two alleles (75). Evidence later followed which identified G4 formation as a 
mechanism responsible for complete ADO events in the MEN1 gene (72). Wenzel et al. (2009) 
showed the reproducible yet unpredictable interaction between G4-DNA and amplification 
efficiency and the heavy dependence upon buffer conditions and magnesium concentration 
(72). Such factors that influence the stability of G4s would have a direct effect on the level of 
amplification observed – whether it be a preferential bias or a complete loss of allele (ADO). 
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This was observed in a PCR diagnostic test for Rett syndrome, which is a neurological disorder 
typically affecting woman and is characterised by autistic traits, dementia, ataxia, loss of 
purposeful hand movement and a loss of facial expression (81). Due to the almost exclusive 
incidence of the disorder in females, it was predicted that this was an X-linked dominant 
disorder which is lethal in hemizygous males (81, 82). This theory was later proven correct with 
the discovery of mutations in the X-linked MECP2 gene which encodes a CpG (cytosine and 
guanine dinucleotide) binding protein (82). Clinical diagnostic tests for Rett syndrome often 
involve PCR and sequencing (74). ADO has been documented to occur in MECP2 due to the 
destabilization of a G4 (74). A DNA variation of G>T within MECP2 disrupts a G4 motif therefore 
resulting in preferential amplification of the T allele and the appearance of a false homozygote 
(74). Combined, these studies indicate that the presence of G4 structure can influence 
amplification efficiency (72) but also the destabilisation of a G4 in one allele can bias 
amplification (74).  
1.5  Allelic drop-out in Molecular Diagnoses  
Misdiagnoses caused by genotyping errors are a significant threat in a diagnostic laboratory; 
ADO being a substantial contributor to such errors. Medical techniques such as preimplantation 
genetic diagnosis (PGD) and PCR identification of monogenic conditions like cystic fibrosis or 
congenital conditions such as Prader-Willi and Angelman Syndromes are the most well 
documented examples that highlight the need for vigilance towards ADO events.  
1.5.1  Monogenic Disorders and Preimplantation Genetic Diagnosis 
Monogenic disorders can be defined as a disease caused by variation in a single gene, 
compared to multifactorial disorders that arise from a combination of genetic and non-genetic 
factors (83). Monogenic disorders are often diagnosed using PCR assays (84) and therefore at 
risk of ADO.  There are three general categories for single gene disorders: autosomal recessive 
including cystic fibrosis, autosomal dominant such as Huntington’s disease and X-linked 
disorders like haemophilia A (84). Literature that ranges from ADO in relation to primer design 
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(1) to the same phenomenon in medical techniques such as PGD (2) agree that the failure of 
amplifying the mutant allele in a monogenic dominant disease is more serious (1, 2) 
PGD has been recognised as an alternative to prenatal diagnosis of inherited genetic disease (2, 
77, 78). This technique employs in vitro fertilisation (IVF) to create an embryo, of which single 
cells are biopsied and genotyped allowing for the selection of unaffected embryos to be 
transferred to the mother (2, 77, 78). As single cells have minute quantities of DNA (~5-10 pg) 
(77),  many rounds of PCR amplification are required before mutation analysis (77, 78). ADO is a 
challenging obstacle that is faced in PGD (2, 77, 78), but was not originally anticipated (77).  
In PGD, this ADO could lead to the unfortunate transfer and re-implantation of affected 
embryos (2) which defeats the purpose of the procedure. ADO in a recessive disease, whilst not 
as detrimental, can still lead to a decrease in the number of heterozygous embryos detected 
(2). This leads to a reduction in the number of embryos transferred and may lower the 
pregnancy success rate (2). Cystic fibrosis is a common genetic disorder where the disease 
phenotype varies and depends on the particular mutation within the CFTR gene, where there 
have been over 2000 mutations identified (85). This was also the first monogenic disorder 
where PGD was successfully applied (86). However, PGD of this recessive disorder can be more 
complex due to the occurrence of compound heterozygotes. Individuals that carry two 
recessive mutations for the same gene, but are mutated in different locations, are referred to 
as compound heterozygotes. This means that both alleles are diseased, but the diseased alleles 
are different. Such a genotype requires accurate identification of parental alleles in order to 
determine the genotype of the embryo (87). Amplification of alleles in a compound 
heterozygote can lead to complicated PCR products, and therefore it can be difficult to 
distinguish between embryos that are homozygote healthy, carriers, or those that have 
suffered ADO (87). Therefore, ADO of an autosomal recessive allele in a compound 
heterozygote can also lead to misdiagnosis and the transfer of a diseased embryo (87) 
1.5.2  Prader-Willi and Angelman Syndromes 
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are genetic diseases that arise from 
contrasting patterns of imprinting at chromosome 15q11-q13 (88-90), the PWS/AS critical 
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region (88). The loss of one or more paternally inherited alleles at this locus results in PWS, 
whereas AS is caused by the loss of the maternal allele of the gene UBE3A (88-90). These 
mutations are most commonly caused by interstitial deletions of the PWS/AS critical region but 
can also be due to both maternal and paternal uniparental disomy (88). Prader-Willi patients 
are characterised by moderate mental retardation, infantile hypotonia, gonadal hypoplasia, 
hyperphagia and obesity (89, 90). Sufferers of Angelman syndrome can have severe mental 
retardation, seizures, speech difficulties, ataxic gait, protruding tongue and a happy demeanour 
often accompanied with inappropriate laughter (89, 90). As these disorders are the result of 
deletions, PCR based methods using primers specific to the critical region can identify 
individuals with the mutation, where the absence of amplification is a positive result of PWS/AS 
(89). One such identification protocol is methylation-sensitive PCR (MSP), in which genomic 
DNA is treated with sodium bisulfite to induce a specific base change in non-methylated DNA 
(89). As PWS and AS are due to deletions of imprinted genes, differences in methylation 
patterns can indicate diseased genotypes. As with a traditional PCR assay, MSP is also limited by 
ADO events that give false positive results (89) which may contradict clinical diagnosis. While no 
ideal prevention of ADO has been established, avoidance of misdiagnoses can occur via 
multiple testing and a reliance on both clinical and genetic analysis, which remains the common 
conclusion amongst the literature.  
1.6   DNA Methylation and Genomic Imprinting 
1.6.1   General Background 
DNA methylation is an epigenetic signal which adds to the information content of the genome 
and is best known for involvement in transcriptional regulation and chromatin architecture (91-
93). The literature is rich in information that agrees not only on the occurrence of methylation 
but also the importance of such DNA characteristics. Currently, it has been observed that 5-
methylcytosine is the foremost methylated base and that this predominantly occurs in the DNA 
methyltransferase substrate 5’-CpG-3’ dinucleotides (3, 93, 94). It is widely accepted that this 
dynamic transcriptional regulator (3) does so by either hypomethylation or hypermethylation, 
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where the latter is associated with gene silencing and the former is found with transcriptionally 
active genes (91-93). Clusters of CpG dinucleotides are commonly referred to as CpG islands but 
differential non-random patterns of methylation within CpG islands have been observed (94). 
CpG islands are distributed throughout the genome; however those found in promotor regions 
have an unexpectedly low level of DNA methylation compared to CpGs in other regions of the 
genome (94).  
1.6.2   Methylation and G-quadruplexes 
Research focusing on methylation and chromatin architecture dominates the literature 
compared to the effect that methylation contributes to secondary structures within CpG islands 
(92, 94). This limited understanding is surprising considering the knowledge that altered 
methylation states are involved in diseases including cancer (94). Whilst the relationship 
between G4s and DNA methylation has yet to be completely resolved (3), it has been 
determined that cytosine-cytosine pairing stabilises the G4 and this can be further stabilised by 
cytosine methylation (3, 4). It has also been shown that certain DNA methyltransferase 
enzymes preferentially methylate secondary structures, which also hints at a significant 
relationship (3, 94). Additionally, further indication of a functional interaction may lay in the 
evolved separation of G4 motifs and methylated CpG islands (3, 94). This separation was 
questioned due to the observation that G4 motifs are commonly found in promotor regions and 
that CpG islands within promotor regions are generally unmethylated (Section 1.6.1) (94). 
Halder et al. (2010) investigated whether CpG dinucleotides within G4 motifs affect the 
methylation status by examining more than 2.1 million CpG dinucleotides across 12 tissues. CpG 
dinucleotides within G4 motifs were found to be relatively depleted of methylated DNA (94). 
Analysing over 600,000 CpG dinucleotides across 18 individuals further confirmed these results 
(94). The data presented by Halder et al. (2010) suggests that G4 structure has a role in CpG 
methylation. The separation suggests an evolutionary pressure through natural selection 
against co-localisation; as the enhanced thermal stability of methylated G4-DNA (92) may 
hinder the cell’s ability to resolve such structures, thereby increasing detrimental effects on 
transcription and other cellular processes.  
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1.6.3  Genomic Imprinting 
Conversely, the literature is rich in agreement over the crucial role that DNA methylation has in 
the epigenetic phenomenon of genomic imprinting. Typically in mammalian cells it is expected 
that alleles from both parents contribute equally during gene expression, however, genomic 
imprinting provides exceptions to this rule (95) . Instead the subset of genes that do experience 
imprinting undergo mono-allelic expression that is in a specific parent-of-origin manner; so that 
some genes are expressed only from the maternally inherited copy and some only from the 
paternally inherited copy (3, 93, 95, 96). Genomic imprinting is required for normal 
developmental growth and behaviour and is also involved in human disease (3, 96-98). The 
majority of imprinted genes contain differentially imprinted regions which are dependent upon 
the allele’s parent-of-origin (97). Therefore, within the genome there are imprinted genes that 
are heavily methylated and may have the potential to form G4 structures; thereby bringing 
methylated DNA and G4-DNA into proximity which is not typically observed within a gene 
promotor region.     
1.7   Research Focus and Hypotheses 
From the literature it is clear that there is a lack of in-depth knowledge and experimental 
confirmation on the role that the combined affect of G4 formation and cytosine methylation 
have on ADO. There is only one exception; a study from this laboratory by Stevens et al. (2014), 
who demonstrated that the methylated maternal allele of the MEST gene undergoes consistent 
ADO during PCR and that both G4 formation and DNA methylation were mechanistically 
responsible. These results were obtained by employing both traditional and methylation 
specific PCR and in vitro methylation techniques. The experimental procedure of the study was 
a simple yet efficient design which compared both the individual and additive effects of G4-
DNA and methylation on ADO events during PCR (3). However, Stevens et al. (2014) found that 
cytosine methylation decreased the thermal stability of the G4 structure, which disagreed with 
previous reports (4). Rather, it appeared that the methylation aided in the rapid re-folding back 
to the G4 state.  
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The research project presented here builds on and extends the findings of Stevens et al. (2014), 
whereby imprinted loci other than MEST were investigated for the same ADO behaviour. This 
work raised the question of whether the in vitro behaviour of MEST is unique or if imprinted 
genes are more widely affected by G4 formation and cytosine methylation. The aim was 
therefore to identify other imprinted genes that contained a G4 motif and determine through 
PCR techniques and in vitro methylation experiments whether ADO due to the combined 
effects of methylation and G4-DNA was observed at a range of loci.  
My primary research hypothesis was that imprinted, methylated G4-containing regions in the 
genome often suffer ADO during PCR. A secondary hypothesis was that methylated cytosines 
need to occur within the G4-DNA motif rather than the flanking regions, in order to cause ADO. 
This project aimed to further improve our understanding of the relationship between G4 
structures and methylation, which could have importance in future studies involving these two 




2   Materials and Methods 
2.1  Imprinted Gene Selection  
Imprinted genes were obtained from two independent databases: Catalogue of Parent of Origin 
Effects (99) and the Geneimprint database (100). Only genes with a confirmed imprinting status 
in both databases were included for this analysis and the genetic sequence of each was 
obtained from UCSC Genome Browser (101). The imprinted gene sequences searched for 
appropriate target regions included the promotor regions (1000bp upstream of the TSS) and all 
intronic and exonic regions.  
2.2   Bioinformatics 
Imprinted gene sequences were then assessed for G4 potential using QGRS Mapper (26) which 
annotates potential G4 forming motifs, according to a “G-score”. Parameter settings used were: 
30 nucleotide maximum motif length, 3 nucleotide minimum G-group size, and a 0 to 7 
nucleotide loop size. Final motifs selected required a nearby CCGG endonuclease recognition 
sequence (for reasons described in section 2.9) and were restricted to the situation where a 
single G4 motif was present on both strands, across a 250~ bp region. Only G4 motifs consisting 
of a G-score of 37 or higher which met these criteria were selected for investigation.  
Geneious 8.1.4 software (Biomatters Ltd, Auckland, NZ) was used for all primer designs, 
sequence alignments and for analysing Sanger DNA sequencing results.  
2.3   DNA Source and Concentration 
Genomic DNA from an anonymous laboratory sample was used to establish the assay and was 
extracted before the commencement of the project. The DNA sample was extracted from 
peripheral blood samples using guanidium chloride extraction, followed by isopropanol 
precipitation (102).  The concentration of the DNA was verified using a NanoDrop 
spectrophotometer (Bioline, Wilmington, DE, USA) which was cleaned and blanked prior with 
Milli-pore purified water (MPW). Concentration was determined through analysis of the 
absorbance at 260nm.  
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2.4  Primer Design and Amplification  
2.4.1   Primer Design 
Primers (Table 1) were designed to generate amplicons of about 150-300 bp encompassing 
each G4 and CCGG site. Regions that had no desirable primer locations, or that contained 
multiple G4 motifs within both strands were discarded. Primer length was kept above 18 
nucleotides in order to avoid issues with secondary hybridisation sites (103). Where possible, 
differences in Tm values between primers were kept at less than 10
oC. UCSC Genome Browser 
In silico PCR function (101) was used to limit the potential for non-specific primer binding at off-
target locations in the genome, and primers that failed this test were redesigned or discarded.  
In order to test for ADO by Sanger sequencing, single nucleotide polymorphisms (SNPs) are 
required. Naturally occurring polymorphisms in each selected imprinted region were not 
investigated as this would have greatly reduced the amplicons that could be studied, and 
required analysis of potentially large numbers of genomic DNA samples. Rather, artificial SNPs 
were introduced by PCR to construct an artificial “allele variant” for each amplicon.  Therefore 
for each amplicon, a second primer was used to introduce a single novel base (Figure 8). This 
second primer was a longer oligonucleotide corresponding to the forward primer for each 
amplicon, which included 4-7 nucleotides at the 3’ end and allowed incorporation of a variant 
base during PCR. Generally, the added artificial SNP was an adenine (A) being exchanged for a 
guanine or a cytosine but on three occasions a thymine (T) base replaced an adenine (Table 1). 
In order to avoid disrupting primer binding and hinder amplification, the SNP was positioned 
towards the 3’ end of the forward primer. Generally, longer primers gain higher Tm values as do 
CG rich sequences and thus a delicate balance arose between sequence homology upstream to 
the introduced SNP and Tm values between the forward and reverse primers.   
Primers were commercially synthesised (Integrated DNA Technologies, Singapore) and Tris 
EDTA (TE) was used to reconstitute the primers to a 50µM stock primer concentration. Primer 





Figure 8 Synthetic variant generation via PCR directed mutagenesis.  
The two AIM1 forward primers are shown, where pfAIM1 is the wild-type primer in green and 
pfAIM1 SNP in purple is the primer that introduces the SNP. The SNP is represented by the 
yellow A. The wild-type primer will be extended and will incorporate a G at base pair position 
23. The variant primer is 26 base pairs in length and therefore the introduced SNP A will be 
incorporated into the sequence at base pair 23. This design ensures that the wild-type primer 




 Table 1 Designed primers and associated Tm values 
Primer Name Sequence 5’ to 3’ Tm  (
oC) 
pf AIM1 


















pr BLCAP (B) 




















































































































































































2.4.2   Polymerase Chain Reaction 
Sterile filter pipette tips and 200 µl strip tubes were used for all PCR, and pipettes were treated 
with UV for 10-15 minutes prior to use. Pre-PCR work was carried out in a separate clean area 
to avoid contamination with post-PCR products. Unless stated otherwise a reaction volume of 
100 µl was used in PCR amplification procedures. This volume contained 1 x PCR Reaction 
Buffer (Solis Biodyne, Estonia) with 1.5mM MgCl2 (Solis Biodyne, Estonia) 0.5µM for both 
forward and reverse primer, 0.2mM dNTP (Fisher Biotec, Wembley WA, Australia), 1M betaine, 
1U Fisher Taq-ti polymerase (Fisher Biotec, Wembley WA, Australia) and approximately 30ng of 
genomic DNA.  
PCR was performed using Eppendorf Mastercycler EP Gradient S Thermal Cycler for all DNA 
amplification procedures. 
2.4.3   PCR Optimisation 
Gradient PCR is a PCR cycling protocol which allows for evaluation of up to 12 annealing 
temperatures within a single run. This approach identifies the optimal primer annealing 
temperature for amplification of the desired region. A master reaction mix of volume 120 µl 
was made and split into 12 individual reactions. The predicted temperature gradient ranged 
from 54.8oC to 68oC in approximately 1.1oC increments. Gradient PCR conditions consisted of 
an initial denaturation step of 94 oC for 2 minutes, followed by 30 cycles of 94 oC for 15 seconds, 
55oC to 68oC annealing temperatures for 15 seconds, and 72oC for 45 seconds with a final 
extension of 72oC for 5 minutes.  
Based on the most efficient primer annealing temperatures indicated by the gradient PCR, 
standard PCR reactions were carried out at these specific temperatures in order to obtain 
optimum amplification. Master reaction mixes of 100 µl were split equally between 5 identical 
reactions in order to achieve consistent annealing temperatures by ensuring efficient heat 
transfer. Optimised PCR conditions consisted of an initial denaturation step of 94oC for 2 
minutes, followed by 35 cycles of 94oC for 15 seconds, the optimised annealing temperature for 
15 seconds and 72oC for 30 seconds with a final extension of 72oC for 4 minutes. 
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2.5  Agarose Gel Electrophoresis  
Agarose gel electrophoresis was used to visualise PCR products in order to determine whether 
amplification was successful and the amplicon was of the appropriate size.  
2.5.1   Gel Assembly   
Molecular grade agarose powder (Duchefa Biochemie, Haarlem, The Netherlands) was 
dissolved in boiling 1x Tris base, acetic acid and EDTA (TAE) buffer to generate a 1.7% (w/v) gel 
solution. 4 µl of SYBR® Safe DNA (Invitrogen, Auckland, NZ) was added to every 100ml of gel 
solution. This solution was poured into a casting tray set in an Easy Cast TM electrophoresis 
system (Thermo Scientific, Owl Separation Systems) and a comb to form wells was placed near 
the anode end.  
2.5.2   Electrophoresis   
When the gel was set, the comb was removed and the gel was fully submerged in 1x TAE 
loading buffer. 3 µl of sample was combined with 1 µl of loading dye (Kapa 6x loading dye) 
before being loaded into the wells of the gel. Adjacent to this 2 µl of a DNA ladder (Kapa 
Universal Ladder) was loaded, and the gel was electrophoresed at approximately 95V for 30-45 
minutes, or until the dye had migrated three quarters the length of the gel. The gel was then 
placed into a gel imaging system (UVItec Alliance 4.7, Cambridge, UK) for the visualisation of 
PCR products under UV light. The gel image was captured using this system and stored as a 
JPEG or TIF file.  
2.6  DNA Purification 
The remaining samples were added to an AcroPrep (PALL Corporation, NY, USA) 96 well filter 
plate (omega 30K) and spun in a Eppendorf 5810‐R centrifuge at 2660 rcf for 20 minutes. The 
samples were re-suspended in 10 µl of MPW, and DNA concentration was then obtained using 
a NanoDrop spectrophotometer (Bioline, Wilmington, DE, USA). DNA samples were sub-
sequentially stored at -20oC.  
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2.7  Gel Extraction 
Gel extraction was performed on template mixing PCRs (Section 2.10) that showed non-specific 
bands during PCR visualisation. Extracting the band at the appropriate size allowed for the 
removal of the non-specific bands in the purified PCR product. iNtRON Biotechnology 
MEGAquick-spinTM Total Fragment DNA Purification Kit (Gyeonggi-do, Korea) was used as 
recommended by the manufacturer’s protocol, including the addition of isopropanol.  
2.8   Sanger Sequencing 
Sequencing was performed using PCR products, which were purified by size exclusion 
centrifugation on AcroPrep (PALL Corporation, NY, USA) 96 well filter plate (omega 30K) in a 
Eppendorf 5810‐R centrifuge and re-suspended in water (Section 2.6) or gel extracted (Section 
2.7). Products were sequenced using BigDye Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, Foster City, CA, USA). DNA Sequencing reactions were carried out in 10 µl volumes. 
Each reaction contained 1 x Cycle Sequencing Buffer (BigDye Terminator v3.1), 1 x of 
appropriate primer, ~10ng of purified DNA amplicon in 1 µl, 0.5 µl Cycle Sequencing enzyme 
(BigDye Terminator v3.1) and MPW to volume. For sequencing of purified DNA sample, two 
reactions with both the forward and reverse primer were used. However sequencing of 
template mixing products (Section 2.10) could be carried out only with the reverse primer, as 
the introduced artificial variant is located adjacent to the forward primer. Cycle sequencing was 
then performed with a an initial denaturation stage of 96oC for 1min, followed by 30 cycles of 
96oC for 10 seconds, 55oC for 15 seconds and 60oC for four minutes. Sequencing was 
outsourced to Canterbury Health Laboratories, Christchurch.  
2.9  In vitro Methylation 
The methyltransferase enzyme M.SssI (Thermo Fisher Scientific Inc., Waltham, MA, USA) was 
used to methylate CpG dinucleotides within the purified PCR amplicons. DNA methylation was 
carried out in 80 µl reaction volumes. Each reaction contained ~400 ng of DNA, 1x M.SssI buffer 
(Thermo Fisher Scientific Inc., Waltham, MA, USA), 1X SAM (Thermo Fisher Scientific Inc., 
Waltham, MA, USA), 1.5 µl M.SssI and MPW to 80 µl volume. Enzyme modification was 
completed in a thermal cycler.  The reaction was incubated at 37oC for 20 minutes, followed by 
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20 minutes at 65oC according to the manufacturer’s protocol. DNA concentration of methylated 
DNA was checked using the NanoDrop spectrophotometer (Bioline, Wilmington, DE, USA) 
(Section 2.3).   
In order to determine the success of in vitro methylation, restriction digest by HpaII (New 
England Biolabs Inc., Ipswich, MA, USA) and MspI (Fermentas, Waltham, MA, USA) 
endonucleases were used. Both enzymes have the recognition site CCGG where cleavage occurs 
at the internal cytosine residue.  MspI can cleave this site when the internal cytosine residue is 
methylated, whereas cleavage by HpaII is blocked (104). Therefore, comparing the size of 
products generated after these two treatments with gel electrophoresis indicates whether or 
not cleavage has occurred, and therefore if methylation was successful. Reactions were carried 
out in 30 µl volumes which contained 1x NEBuffer 1, 10 µl of methylated DNA, 0.5U enzyme 
and MPW to volume. Reactions were incubated at 37oC for one hour followed by 65oC 
denaturation for 20 minutes. Digestion products were assessed by gel electrophoresis as 
described above (Section 2.5). 
2.10   Template Mixing Assay  
The template mixing assay (illustrated in Section 3) required the mixing of two differentially 
methylated wild-type and variant templates. Various combinations of methylated and 
unmethylated templates were mixed. Templates were diluted to 1ng/µl in 100 µl volumes. PCR 
varied from the standard procedure in that a total reaction volume of 30 µl was used. This 
consisted of 1 x PCR Reaction Buffer (Solis Biodyne, Estonia) with 1.5mM MgCl2 (Solis Biodyne, 
Estonia) 0.5µM for both wild-type forward and reverse primer, 0.2mM dNTP (Fisher Biotec, 
Wembley WA, Australia), 1U Fisher Taq-ti Polymerase (Fisher Biotec, Wembley WA, Australia) 
and a total of 1ng of PCR product DNA (0.5ng per DNA template). Optimised PCR cycling 
conditions for each amplicon were used again for consistency and best amplification yield. 
Agarose gel electrophoresis (Section 2.5) was used to visualise products followed by DNA 
purification (Section 2.6) and sequencing (Section 2.8). To ensure detection of both alleles, only 
the reverse primer was used for Sanger sequencing. Template mixing followed by sequencing 
was repeated three times for each working amplicon. 
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2.11   Circular Dichroism Spectroscopy  
Oligonucleotides were commercially synthesised (Integrated DNA Technologies, Singapore), 
and were reconstituted to 1 nmol per µl in MPW. Six nmol of oligonucleotide was added to 10 
mM Tris-HCl pH 7, where experimental conditions contained 50 mM KCl and 1.5 mM MgCl2 in 1 
ml volumes. Samples were heated at 95oC for 10 minutes then gradually cooled to room 
temperature overnight prior to CD analysis. CD measurements were performed on a Jasco J-815 
CD Spectrometer (Jasco Analytical Instruments, Maryland, USA) with 700 µl of sample. The 
presented spectral profiles correspond to the average of three scans where an appropriate 
buffer blank was subtracted from each spectrum. Analyses were performed using a 1 mm path 
length quartz curvette, and the sample temperature was controlled using a Peltier temperature 
controller. CD spectrum were obtained across 320 to 200 nm at either 20oC or 95oC using a 
scanning speed of 100nm/min, and a band width of 1 nm. Data was exported as a text file and 




3   Results 
ADO during PCR causes misinterpretation of genotyping results which can lead to downstream 
diagnostic errors. It was observed that the imprinted MEST locus undergoes ADO due to 
methylated G4s (3); however it was unclear if this was a unique behaviour restricted to MEST, 
or if it was a more global characteristic of imprinted genes that contain G4-DNA. This work 
aimed to address this question by examining a range of selected amplicons from imprinted loci. 
For this purpose, a “template mixing” PCR assay that could be applied to many different 
amplicons was developed. This meant that each locus could be tested for ADO, without the 
constraint of having to find natural SNPs in the regions of interest.  
The template mixing assay (Figure 9) required two templates for each amplicon, both identical 
apart from an “artificial SNP” introduced in one amplicon by PCR-directed mutagenesis (Figure 
8 and Figure 9). These represented two different alleles, as would be found in heterozygous 
genomic DNA. Samples of these templates were then methylated in order to generate four 
different templates for each amplicon: wild-type template, variant template, and then 
methylated versions of both templates. Pairs of two templates were mixed such that a non-
methylated template was mixed with the alternate methylated template at equal 
concentrations. Therefore, these mixed DNA templates would represent different methylation 
states of diploid genomic DNA. For an experimental control the two non-methylated templates 


























Figure 9 Template mixing assay.  
Green lines represent gene target region and grey lines represent flanking DNA. Assay requires 
the presence of two templates, referred to as a wild-type template and a variant template. 
Primers (short arrows) are used to selectively amplify gene target. Green primers are wild-type 
and the purple is the longer primer that introduces the SNP (yellow line). Separate PCR 
reactions using these primers create amplicons for both templates. These two templates were 
then subjected to in vitro methylation to generate a total of four templates. To determine if 
methylation, G4 formation or both are responsible for ADO, these templates were mixed 
together in PCR followed by DNA sequencing. Sanger sequencing would reveal either ADO due 
to the sole presence of the non-methylated template, or the bi-allelic (heterozygous) state 
where both the methylated and the non-methylated templates would be detected.  
3.1  Identifying Target Regions 
We wished to focus this study on imprinted gene regions containing G4. The Catalogue of 
Parent of Origin Effects (99) and Geneimprint (100) databases were manually analysed to 
identify genes which display parent-of-origin expression. The selected genes were cross-
referenced with Baran et al. (2015) (105) and a total of 53 imprinted genes (Table 2) were 
selected for analysis using bioinformatics prediction algorithms.  
Gene sequences were assessed for potential G4 motifs using QGRS Mapper (26) and only G4 
motifs with a high predicted G4 propensity were selected, as these were most likely to adopt 
G4 structure. Repetitive G-rich regions are notoriously difficult to amplify  (106, 107) and to 
avoid compounding effects of these repeating nucleotides, only regions that contained one G4 
motif were selected. 22 regions from 16 genes passed the criteria and these regions are shown 
in Table 3 and Table 4.  
41 
 
Table 2 Imprinted genes pooled from Catalogue of Parent of Origin Effects and Geneimprint.  
Gene Name 
AIM1 IGF2* MESTIT1 RTL1** 
BLCAP INS MIMT1† SGCE 
CDKN1C KCNK9 MKRN3 SGK2* 
COPG2‡ KCNQ1* NAA60 SLC22A18AS 
CPA4* KCNQ1DN NAP1L5* SLC22A2 
DLGAP2** KCNQ1OT1 NDN* SLC22A3 
DLK1* KLF14 NNAT SNURF* 
DNMT1 L3MBTL1* NPAP1 TCEB3C† 
FAM50B* LRRTM1** PEG10* TFPI2 
GNAS‡ MAGEL2* PEG3* ZDBF2* 
GPR1-AS** MCTS2P† PHLDA2 
ZNF597* 
GRB10* MEG3* PLAGL1* 
H19* MEG8* PPP1R9A 
HYMAI MEST* RB1‡ 
 *Genes found to be imprinted by Baran et al. (2015) 
**Genes with suggested imprinting status by Baran et al. (2015) 
† Genes that lacked data in Baran et al. (2015) analysis 
‡ Genes discarded due to evidence quality concerns by Baran et al. (2015) 
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Table 3 Selected genes and corresponding G4 motifs  
* Guanines involved in the G4 motif are bold and underlined. Red nucleotides represent CpG dinucleotides 
** G-score obtained from QGRS Mapper (26) 
Gene G-quadruplex motif* G-score** 
G4 motifs which do not contain methylation sites 
GRB10 GGGTGGGGGAGGGCTGGG 42 
PLAGL1 GGGGTTGGGGGAAAGGGGTTTGGG 42 
G4 motifs which contain methylation site at the flanking region G4 boundary only 
AIM1 CGGGGGGGATGGGGGGTGGTAGGG 37 
GRB10 (C)  CGGGGAAGCTGGGAGTGGGGAATGGG 40 
KCNQ1 CGGGGACTGGGGCTGGGGCTGGGG 62 
G4 motifs which contain methylation sites 
BLCAP GGGGAGGTGGGGGGACGTGGGGGTGAGGGG 62 
BLCAP (B) GGGGGGTGGGGGCGGTGGGGGGGGG 60 
DLGAP2 GGGAGCCGGGGACCAGGGCAGACGGG 41 
DNMT1 CGGGGGCTGGGGGCTGAGGGCCGGTTGGG 41 
DNMTI (B) GGGCCCTGGGGCTGGGGCGGG 40 
GRB10 (B) GGGCGCGGGGTGGGGGTGGGG 42 
IGF2 CGGGCCGGGGGCGGGGCGAGGG 42 
LRRTM1 GGGCAGCCGGGACGGGCCGGCGGG 39 
MEG3 GGGCGGGCCGGGGGG 40 
MEG3 (B) GGGGCGGGAGGGGTTCAGGG 40 
MEG8 CGGGGTGGTCGGGGCGGGGGGCGGGG 60 
NAA60 CGGGGCGCCGAGGGGGCGGGGTAGGCGGGG 59 
NPAP1 GGGGTCCTGGGGCAGCTGGGGCCGACGGGG 62 
RB1 GGGAGCCGGGGCTGGGAGCTGGG 41 
RB1 (B) GGGAGGCGGCGGGCCCGGGTCTCTGGGG 38 
SLC22A3 GGGCTGGGCTCCCGGGGACTCGGG 39 
ZDBF2 CGGGTCCGGGCTTGGGGAGGGG 42 
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Table 4 Imprinted gene information 
Gene Name Chromosome Gene Function Expressed Allele Diseases associated with 
genetic mutations in 
sequence or imprinting 
status 
AIM1 - Absent in melanoma 1 
protein 
Chr: 6 May function as a malignant melanoma 
suppressor.  
Paternal Albinism (108) and melanoma (109) 
BLCAP – Homo sapiens 
bladder cancer associated 
protein 
Chr: 20 Tumour suppressor protein that reduces 
cell growth by stimulating apoptosis. 
Isoform Dependent Cancer (Bladder (110)  and Cervical 
(111)) 
DLGAP2 – Homo sapiens 
discs large homolog 
associated protein 2 
Chr: 8 Membrane associated protein that may 
play a role in synapse organisation and 
signalling in neuronal cells. 
Isoform Dependent  Susceptible gene of schizophrenia 
(112) 
DNMT1 – Homo sapiens DNA 
(cytosine-5-)-
methyltransferase 1 
Chr:19 Establishment and regulation of tissue-
specific patterns of methylated cytosine 
residues. 
Paternal Hereditary sensory and autonomic 
neuropathy and autosomal 
dominant cerebellar ataxia (113, 
114) 
GRB10 – Homo sapiens 
growth factor receptor-
bound protein 10 
Chr: 7 Encoded protein interacts with insulin 
receptors and insulin-like growth-factor 
receptors. 
Isoform Dependent Silver-Russell syndrome (115) 
IGF2 – Homo sapiens insulin-
like growth factor 2 
Chr: 11 Encodes a member of the insulin family of 
polypeptide growth factors which are 
involved in development and growth. 
Paternal Beckwith-Wiedemann syndrome 
(116), rhabdomyosarcoma (117) 
KCNQ1 – Homo sapiens 
potassium voltage-gated 
channel 
Chr: 11 Voltage-gated potassium channel required 
for repolarization phase of the cardiac 
action potential.  
Isoform Dependent Romano-Ward syndrome, Beckwith-
Wiedemann syndrome and Jervell 




LRRTM1- Homo sapiens 
leucine rich repeat 
transmembrane neuronal 1 
Chr: 2 Encodes protein that interacts with 
neurexins and neurologins to modulated 
synaptic cell adhesion in neurons 
Paternal Handedness and schizophrenia 
(120) 
MEG3 – Maternally 
expressed 3 (non-protein 
coding) 
Chr: 14 Evidence indicates formation of lncRNA 
tumour suppressor. 
Maternal Tumour growth (121), Silver Russell 
and Temple syndromes (122) 
MEG8 – Maternally 
expressed 8 (non-protein 
coding) 
Chr: 14 Forms lncRNA Maternal Little known about function in 
humans  
NAA60 – N(alpha) 
acetyltransferase 60 
Chr: 16 Histone acetyltransferase in the Golgi 
apparatus that mediates nucleosome 
assembly 
Isoform Dependent  No association found.  
NPAP1 – Homo sapiens 
nuclear pore associated 
protein 1 
Chr: 15 May be involved in spermatogenesis and 
associates with the nuclear pore complex. 
Isoform Dependent Prader-Willi Syndrome (123) 
PLAGL1 – Homo sapiens 
pleomorphic adenoma gene-
like 1 
Chr: 6 Encodes a zinc finger protein with 
transactivation and DNA binding activities. 
Also thought to function as a tumour 
suppressor.  
Isoform Dependent Transient neonatal diabetes 
mellitus (124)  and Beckwith-
Weidemann syndrome (125) 
RB1 – Homo sapiens 
retinoblastoma 1 
Chr: 13 Negative regulator of cell cycle and tumour 
suppressor. Maintains overall chromatin 
structure. 
Maternal  Childhood cancer Retinoblastoma 
and other cancers  (126, 127) 
SLC22A3 – Homo sapiens 
solute carrier family 22 
Chr: 6 Polyspecific cation transporter Maternal Colonic Neoplasms (128), Coronary 
heart disease (129) and 
methamphetamine dependence 
(130) 
ZDBF2 – Homo sapiens zinc 
finger DBF-type containing 2 
Chr: 2 Nucleic acid and zinc ion binding Paternal No association found 
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3.2   PCR Amplicons 
Gradient PCRs were used to determine the optimal primer annealing temperature, which 
maximises amplification yield and specificity. Due to the variant primer having a higher Tm than 
the corresponding reverse primer (Table 1), gradient PCRs were also performed on these 
primers. An example of gradient PCR products is shown in Figure 10 (and results for all 
amplicons are shown in Appendix 1). The optimal annealing temperatures and resulting PCR 
annealing temperatures are shown in Table 5. The optimum annealing temperature is 
represented by the column that had no non-specific bands and the best amplification, indicated 
by the darkest band. For several of the PCRs, the primers showed good amplification across the 
entire or partial range of the gradient (Table 5 and Appendix 1), when this occurred the 
temperature from the middle of the range was selected. Complete failure of amplification 
occurred in five of the samples and three displayed very faint bands (Table 5). G-rich sequences 
are known to be difficult to amplify (106, 107) and even with the use of multiple polymerase 
enzymes and varied PCR conditions, amplification of these regions was unsuccessful.  
Subsequent PCRs were based on the optimal annealing temperature for each primer pair (Table 
5). Primer dimers are often observed during PCR (71) and were visible in a number of 
amplification reactions even at optimal primer  annealing temperatures. However, the primer 
dimers were not considered problematic and were removed with size exclusion centrifugation. 





Figure 10 Gel electrophoresis visualisation of gradient PCR.  
PCR was conducted on the RB1 231 bp amplicon. Kapa Universal Ladder is in the leftmost lane, 
where the next 12 lanes are the gradient PCR product ranging from approximately 54.8oC to 
68oC (2 to 13).  Amplification of RB1 occurs at lower annealing temperatures, where 
amplification becomes increasingly inefficient at higher temperatures. Lanes 3-5 (black box) 
show the best amplification conditions of RB1, which correspond to approximately 55.1oC, 
55.9oC and 57.1oC respectively. Therefore, a PCR protocol where the annealing temperature is 
~55oC would be expected to give the best amplification for this DNA region. Base pair size 












Table 5 Optimal annealing temperatures and selected PCR annealing temperature. 
Amplicon Optimal Temperature Range PCR Annealing Temperature** 
AIM1 54.8 - 55.9oC 55oC 
AIM1 SNP 54.8 - 55.9oC 55oC 
BLCAP 60.3 - 65.4oC 60oC 
BLCAP SNP 57.1 - 60.3oC 60oC 
BLCAP (B) 55.9 - 63.8oC 60oC 
BLCAP (B) SNP 57.1 - 60.3oC 60oC 
DLGAP2  55.9 - 62.1oC 57oC 
DLGAP2 SNP 57.1 - 63.8oC 60oC 
DNMT1 55.9 - 60.3oC 60oC 
DNMT1 SNP 57.1 - 58.6oC 57oC 
DNMT1 (B) 62.1oC  60oC 
DNMT1 (B) SNP 60.3 -  63.8oC 60oC 
GRB10 57.1oC 57oC 
GRB10 SNP 55.9 - 58.6oC 57oC 
GRB10 (B) 55.9 - 60.3oC 57oC 
GRB10 (B) SNP 54.8 – 57.1oC 57oC 
GRB10 (C) FAILED  -  
IGF2 FAILED - 
KCNQ1 54.7 - 68.0oC 63oC 
KCNQ1 SNP 54.7 -  68.0oC 63oC 
LRRTM1 FAILED - 
MEG3 54.8 - 60.3oC 60oC 
MEG3 SNP 55.9 – 60.3oC 60oC 
MEG3 (B) 57.1oC 57oC 
MEG3 (B) SNP 60.3 - 63.8oC 60oC 
MEG8 FAILED -  
NAA60 63.8oC * 63oC 
NPAP1 62.1 - 67.6oC * 63oC 
RB1 54.8 - 58.6oC 55oC 
RB1 SNP 54.8 – 68.0oC 60oC 
RB1 (B)  FAILED - 
PLAGL1 54.7 - 68.0oC 63oC 
PLAGL1 SNP 55.1 - 67.6oC 63oC 
SLC22A3 55.1 - 57.1oC 55oC 
SLC22A3 SNP 58.6 - 62.1oC 60oC 
ZDBF2 58.6 - 65.4oC * 63oC 
*faint bands observed at one or more temperatures but failed to amplify in optimised PCR.  
**In order to limit the number of cycling conditions, the PCR annealing temperature was selected as to incorporate multiple 




Table 6 DNA concentration of purified DNA products 
PCR product DNA Concentration (ng/µl) 
AIM1 56 
AIM1 SNP 66 
BLCAP 49 
BLCAP SNP 83 
BLCAP (B)  68 
BLCAP (B) SNP 45 
DLGAP2 67 
DLGAP2 SNP 66 
DNMT1 126 
DNMT1 SNP 94 
DNMT1 (B) 49 
DNMT1 (B) SNP 79 
GRB10  89 
GRB10 SNP 68 
GRB10 (B)  61 
GRB10 (B) SNP 133 
KCNQ1 153 
KCNQ1 SNP 87 
MEG3 41 
MEG3 SNP 47 
MEG3 (B)  52 
MEG3 (B) SNP 78 
PLAGL1 361 
PLAGL1 SNP 180 
RB1 65 
RB1 SNP 242 
SLC22A3 76 
SLC22A3 SNP 55 
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3.3  Implementation of Template Mixing Assay 
This assay was applied to investigate ADO during PCR, using differentially methylated 
templates. In addition, CD spectroscopy of oligonucleotides representing each of the G4 motifs 
was used to verify formation of G4 structure. Each of the genes from which an amplicon was 
derived is introduced in more detail below with a summary of disease associations, and the 
results of these analyses are then described.  
Prior to use in mixing experiments, the methylation status of DNA templates were confirmed 
using the enzymes HpaII (New England Biolabs Inc., Ipswich, MA, USA) and MspI (Fermentas, 
Waltham, MA, USA) (Appendix 3). These endonucleases are isoschizomers and recognise the 
cut site 5’ – CCGG – 3’; however Msp1 is not sensitive to mammalian CpG methylation. 
Therefore, if the methylation has been successful, HpaII will not cleave the DNA template but 
MspI will. To confirm successful methylation, this assay was performed on all differentially 





Figure 11 Gel electrophoresis visualisation of HpaII/MspI digestion.  
Enzymatic digestions of the 275 bp GRB10 (B) wild-type template, which would result in 
expected fragments of 130 bp and 145 bp.  Lane 1 shows a Kapa Universal Ladder. Lanes 2 and 
3 show the GRB10 (B) wild-type amplicons treated with HpaII and MspI respectively. The 
treatment with HpaII shows no cleavage of the DNA, whereas the same DNA treated with MspI 
has undergone cleavage, indicating successful methylation.  Arrows indicate base pair size.  
3.3.1   AIM1 
The Homo sapiens absent in melanoma 1 gene (AIM1) is positioned on chromosome 6 (Table 4) 
and is unique in that it is a non-lens member of the βγ-crystallin superfamily (109). AIM1 is an 
imprinted gene, where allele-specific methylation is observed on the maternal allele and has 
paternal allele-specific transcription within the placenta (Table 4) (131). AIM1 is positioned 
close to a locus on chromosome 6 involved in suppression of malignant melanoma and is 
expressed at high levels in melanoma cells (109). SNPs within AIM1 are associated with normal 
human pigmentation variation (108). Mutations that affect the production of pigmentation can 
result in oculocutaneous albinism (OCA)  (108) which is typically characterised by 
hypopigmentation of the skin, eyes and hair (132). OCA Type 4 has been linked to a splice site 
mutation in the AIM1 gene (Table 4) (132).  
The 271 bp amplicon of the AIM1 gene contained one G4 forming motif and is 43.5 % GC with 
three CpG dinucleotides (Figure 12). The CpG position within this G4 motif was located at the 
boundary of the motif (Table 3 and Figure 12). The variant template is represented by an 
adenine nucleotide and the wild-type template is represented by a guanine nucleotide (Figure 





12). When the methylated A template was mixed with the non-methylated G template prior to 
PCR, only the G allele was visible during genotyping (Figure 13A). Conversely, when the 
methylated G template was mixed with the non-methylated A template, only the A allele was 
visible (Figure 13B). When the two non-methylated templates were mixed, both A and G alleles 
were detected (Figure 13C).  
In order to confirm the presence of G4 structure in the template DNA, CD spectroscopy was 
performed on the AIM1 G4 motif (Figure 14). To investigate G4 structure at temperatures and 
conditions relevant to PCR, spectral profiles were obtained at both 20oC (Appendix 5) and 95oC 
(Figure 14) in Tris-HCl buffer.  At 95oC an elliptical minimum around 245 nm and a maximum 
around 260 nm were observed, suggesting the formation of parallel G4 (Figure 14). In the 
absence of KCl and MgCl2 the characteristic G4 spectra is not observed (Figure 14), 
demonstrating that G4 formation is cation dependent. Because the G4 remains stable at 95oC, it 
is likely to be present during PCR and therefore, contributing to drop-out events.  
 
Figure 12 Amplicon of AIM1 region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 




Figure 13 Sanger sequencing of AIM1 template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated G template. B) Template mixing of the methylated 
G template and the non-methylated A template. C) Template mixing of the two non-methylated 





Figure 14 CD spectra of AIM1 G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and the dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.2   BLCAP 
The Homo sapiens bladder cancer associated protein (BLCAP) gene is located on chromosome 
20 (Table 4). This gene has been annotated as a tumour suppressor gene due to its ability to 
induce apoptosis when over-expressed. BLCAP is silenced in bladder cancer (110), cervical 
cancer (111) and renal-cell carcinoma (133). The first intron of the BLCAP locus contains a 
separate distinct gene, neuronatin (NNAT) which is imprinted and paternally expressed in the 
fetal brain (134). Initially, there was no evidence of BLCAP being an imprinted gene, however, it 
is now known that BLCAP is imprinted in the human brain and has isoform dependent 
expression in a tissue specific manner (134). Recently, BLCAP has been investigated for its 
ability to be used as a novel potential biomarker for bladder cancer, as the loss of BLCAP 
expression is associated with tumour progression (135).  
The 234 bp amplicon from the BLCAP gene is 63.2% GC, and contained one G4 forming motif 























































































(Table 3) (Figure 15). The variant template is represented by an adenine nucleotide and the 
wild-type template is represented by a guanine nucleotide (Figure 15). When the methylated A 
template was mixed with the non-methylated G template prior to PCR, the G allele was 
dominant during genotyping, although the methylated A allele was also visible (Figure 16A). 
Conversely, when the methylated G template was mixed with the non-methylated A template, 
only the A allele was visible (Figure 16B). When the two non-methylated templates were mixed, 
both G and A alleles were detected (Figure 16C).  
CD spectroscopy performed on the BLCAP G4 motif demonstrated an elliptical profile consisting 
of a maximum around 260 nm and a minimum near 240 nm at 95oC (Figure 17). This profile was 
suggestive of a parallel G4 and was only observed in the presence of K+ and MgCl2 (Figure 17). 
The profile obtained at 95oC, in the presence of K+ and MgCl2 was consistent with that seen at 
20oC (Appendix 5).  
Figure 15 Amplicon of BLCAP region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 




Figure 16 Sanger sequencing of BLCAP template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated G template. B) Template mixing of the methylated 
G template and the non-methylated A template. C) Template mixing of the two non-methylated 












Figure 17 CD spectra of BLCAP G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.2.1   BLCAP (B) 
The second amplicon from BLCAP is a 245 bp fragment with one G4 forming motif and is 49% 
GC with four CpG dinucleotides; one located within the G4 motif (Table 3 and Figure 18). The 
variant template is represented by an adenine nucleotide and the wild-type template is 
represented by a guanine nucleotide (Figure 18). When the methylated A template was mixed 
with the non-methylated G template prior to PCR, only G allele was visible during genotyping 
(Figure 19A). However, when the methylated G template was mixed with the non-methylated A 
template, only the A allele was visible (Figure 19B). When the two non-methylated templates 
were mixed, both A and G alleles were detected (Figure 19C).  
CD spectroscopy performed on the BLCAP (B) G4 motif demonstrated an elliptical profile 
consisting of a maximum around 260 nm and a minimum at 240 nm at 95oC (Figure 20). This 
profile suggests the formation of a parallel G4 and was only observed in the presence of K+ and 
MgCl2 (Figure 20). The profile obtained at 95
























































































20oC where there was an additional maximum at 290 nm, suggesting antiparallel or mixed 
species (Appendix 5).  
Figure 18 Amplicon of BLCAP (B) region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 19 Sanger sequencing of BLCAP (B) template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated G template. B) Template mixing of the methylated 
G template and the non-methylated A template. C) Template mixing of the two non-methylated 












Figure 20 CD spectra of BLCAP (B) G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.3   DNMT1 
Homo sapiens DNA (cytosine -5-) methyltransferase 1 (DNMT1) gene on chromosome 19 (Table 
4) encodes a DNA methyltransferase protein which is responsible for maintaining the DNA 
methylation patterns during replication (136). DNMT1 is imprinted, showing maternal allele-
specific methylation and paternal allele-specific transcription in the human placenta (131). The 
DNMT1 gene produces two transcripts but expressed in different locations; one in somatic 
tissues while the other is expressed in the oocyte (131). The somatic DNTM1 transcript is 
methylated in a mono-allelic manner in the primate placenta, whereas it is hypomethylated in 
other human tissues (131). Mutations in DNMT1 have been associated with central and 
peripheral neurodegeneration in the form of hereditary sensory autonomic neuropathy with 
dementia and hearing loss (113). Autosomal dominant cerebellar ataxia and narcolepsy have 























































































The 224 bp amplicon of the DNMT1 gene had a GC value of 45.1% and contained one G4 
forming motif with three CpG dinucleotides (Table 3 and Figure 21). The CpG dinucleotides 
were positioned within the flanking regions, the G4 boundary and within the motif (Figure 21). 
The wild-type template is represented by a cytosine nucleotide and the variant template is 
represented by an adenine nucleotide (Figure 21). The DNMT1 region was difficult to amplify 
and initially yielded smeared PCR products, however this was resolved by diluting the template 
DNA prior to PCR (Appendix 4). When the methylated A template was mixed with the non-
methylated C template prior to PCR, the C allele was the major peak, although the A allele was 
also visible (Figure 22A). Conversely, when the methylated C template was mixed with the non-
methylated A template, only the A allele was visible (Fig22 B). When the two non-methylated 
templates were mixed, both C and A alleles were detected (Figure 22C).  
CD spectroscopy performed on the DNMT1 G4 motif demonstrated an elliptical profile 
consisting of a maximum at 260 nm and a minimum around 240 nm at 95oC (Figure 23). This 
profile was characteristic of a parallel G4 and was only observed in the presence of K+ and 
MgCl2 (Figure 23). The profile obtained at 95
oC in the absence of K+ and MgCl2 differed from 
20oC where there was an additional shoulder towards 290 nm, suggesting antiparallel or mixed 





Figure 21 Amplicon of DNMT1 region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 22 Sanger sequencing of DNMT1 template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated C template. B) Template mixing of the methylated 
C template and the non-methylated A template. C) Template mixing of the two non-methylated 












Figure 23 CD spectra of DNMT1 G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.3.1   DNMT1 (B) 
The second amplicon from the gene DNMT1 was 285 bp in length, 62.1% GC, contained a single 
G4 motif and 12 CpG dinucleotides with one positioned within the G4 motif (Table 3 and Figure 
24). The variant template is represented by an adenine nucleotide and the wild-type template 
is represented by a cytosine nucleotide (Figure 24). When the methylated A template was 
mixed with the non-methylated C template prior to PCR, only the non-methylated C allele was 
visible during genotyping (Figure 25A). Conversely, when the methylated C template was mixed 
with the non-methylated A template, only the A allele was visible (Figure 25B). When both the 
non-methylated templates were mixed, both C and A alleles were detected, although the A 
peak was significantly larger than the C peak (Figure 25C).  
CD spectroscopy performed on DNMT1 (B) G4 motif demonstrated an elliptical profile 
consisting of a maximum around 260 nm and a minimum around 240 nm at 95oC (Figure 26). 






















































































MgCl2 (Figure 26). The profile obtained at 95
oC, in the presence of K+ and MgCl2 was consistent 
with that seen at 20oC (Appendix 5).  
 
Figure 24 Amplicon of DNMT1 (B) region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 25 Sanger sequencing of DNMT1 (B) template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated C template. B) Template mixing of the methylated 
C template and the non-methylated A template. C) Template mixing of the two non-methylated 












Figure 26 CD spectra of DNMT1 (B) G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.4   GRB10 
Homo sapiens growth factor receptor-bound protein 10 (GRB10) is located on chromosome 7 
(Table 4) and belongs to a family of adapter proteins. GRB10 is mono-allelically expressed in the 
fetal brain, however this imprinting is isoform dependent and tissue specific (137). This protein 
has been shown to bind insulin and insulin growth factors (138).  It had been previously 
predicted that alterations in the imprinting of GRB10 can cause the growth disorder Silver-
Russell syndrome (115), however this is disputed as GRB10 imprinting is absent in the growth 
plate cartilage, which is a tissue that is heavily linked with growth (139).  
The selected region of the GRB10 gene was 200 bp in length, 58% GC and contained one G4 
motif and three CpG dinucleotides, none of which are present within the G4 motif (Table 3 and 
Figure 27). Therefore, this region allows comparison of the degree to which location of CpG 
dinucleotides in relation to the G4 motif matters to ADO. The variant template is represented 
by an adenine nucleotide and the wild-type template is represented by a guanine nucleotide 

























































































prior to PCR, only the non-methylated G allele was visible during genotyping (Figure 28A). 
Alternatively, when the methylated G template was mixed with the non-methylated A 
template, the A allele was the major peak with evidence of a minor G peak (Figure 28B). When 
both the non-methylated templates were mixed, both G and A alleles were detected (Figure 
28C). 
CD spectroscopy performed on the GRB10 G4 motif demonstrated an elliptical profile consisting 
of a maximum at 260 nm and a minimum around 245 nm at 95oC (Figure 29). This profile is 
suggestive of a parallel stranded G4 and was only observed in the presence of K+ and MgCl2 
(Figure 29). The profile obtained at 95oC, in the presence of K+ and MgCl2 was consistent with 
that seen at 20oC (Appendix 5).  
 
Figure 27 Amplicon of GRB10 region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 




Figure 28 Sanger sequencing of GRB10 template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated G template. A secondary SNP (thymine) was 
observed upstream of the introduced A SNP locus in this reaction. B) Template mixing of the 
methylated G template and the non-methylated A template. C) Template mixing of the two 












Figure 29 CD spectra of GRB10 G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.5   KCNQ1 
Located on chromosome 11 is the Homo sapiens potassium voltage-gated channel (KCNQ1) 
gene (Table 4). The channel encoded by this gene is important for the repolarisation phase of 
cardiac action potential and mutations in this gene can cause long QT syndrome, an inherited 
cardiac disorder (119). This gene is associated with two other genetic diseases, the autosomal 
dominant Romano-Ward syndrome, and the autosomal recessive Jervell and Lange-Neilson 
syndrome (119). The KCNQ1 gene is imprinted in a tissue specific manner, with expression of 
the maternal allele in some tissues, and bi-allelic expression in others like the heart (118). 
Beckwith-Weidemann syndrome (BWS) is a disorder associated with prenatal overgrowth and 
cancers, and KCNQ1 is located within a region of imprinted genes that are associated with this 
syndrome (118). KCNQ1 has been shown to be disrupted in chromosomal rearrangements of 























































































A 170 bp region of the KCNQ1 gene was selected for ADO analysis which was 66.5% GC and 
contained one G4 motif and four CpG dinucleotides (Figure 30). Like AIM1, KCNQ1 has a CpG 
dinucleotide located at the G4 motif boundary rather than being located within the motif (Table 
3 and Figure 30). The wild-type template is represented by an adenine nucleotide and the 
variant template is represented by a thymine nucleotide (Figure 30). When the methylated T 
template was mixed with the non-methylated A template prior to PCR, the non-methylated A 
allele was the sole peak visible during genotyping (Figure 31A). Conversely, when the 
methylated A template was mixed with the non-methylated T template, the T template was the 
major peak although a minor A peak was also visible (Figure 31B). When the non-methylated 
templates were mixed, both A and T alleles were detected (Figure 31C).  
CD spectroscopy performed on the KCNQ1 G4 motif at 95oC demonstrated an elliptical profile 
consisting of a maximum at 260 nm and a minimum at 240 nm, which was only observed in the 
presence of K+ and MgCl2  (Figure 32). This profile suggests a parallel G4 structure (Figure 32); 
however, the elliptical maximum value was low. The profile obtained at 95oC differed from 20oC 
where there was a broad shoulder at approximately 290 nm. This profile is suggestive of mixed 
species, however, the peak at 290 nm had largely dissociated at 95oC indicating the parallel G4 





Figure 30 Amplicon of KCNQ1 region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 31 Sanger sequencing of KCNQ1 template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated T template and non-methylated A template. B) Template mixing of the methylated 
A template and the non-methylated T template. C) Template mixing of the two non-methylated 





Figure 32 CD spectra of KCNQ1 G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only. 
3.3.6   MEG3 
Homo sapiens maternally expressed 3 (MEG3) is a non-protein coding gene located on 
chromosome 14 (Table 4). As the name suggests, this is an imprinted gene where the maternal 
allele is expressed and is thought to function as a non-coding RNA (140). This non-coding RNA 
has been found to act as a tumour suppressor through activation of the tumour suppressor 
protein p53 (121, 140). In primary human tumours and tumour cells lines, MEG3 expression is 
lost through a range of mechanisms including hypermethylation of the promotor and gene 
deletion (121). MEG3 has been shown to stimulate expression of the p53 gene and down-
regulate the protein MDM2 which degrades p53 protein, allowing for further accumulation of 
the tumour suppressor protein (121, 140). Therefore when expression of MEG3 is altered, 
abnormal growth of cells may follow (121). Recently, a link between aberrations in the 
imprinting region that MEG3 is located in and Silver-Russell syndrome and Temple syndrome 


























































































A 212 bp region from MEG3 was analysed for ADO. This amplicon was 66% GC with a single 
potential G4 forming motif and eight CpG dinucleotides, two of which are located within the G4 
motif (Table 3 and Figure 33). The variant template is represented by an adenine nucleotide 
and the wild-type template represented by a guanine nucleotide (Figure 33). The MEG3 region 
was problematic to amplify as the PCR yielded smeared products, however this was mitigated 
by diluting the input DNA and reducing the reaction volume (Appendix 4). When the 
methylated A template was mixed with the non-methylated G template prior to PCR, only the 
non-methylated G allele was visible during genotyping (Figure 34A). However, when the 
methylated G template was mixed with the non-methylated A template, the G allele 
predominated and the non-methylated A allele was barely visible (Figure 34B). When the non-
methylated templates were mixed, the G template was the major peak and the A allele was 
again barely visible (Figure 34C).   
CD spectroscopy performed on the MEG3 G4 motif demonstrated an elliptical profile consisting 
of a maximum at 260 nm and a minimum around 240 nm at 95oC (Figure 35). This profile 
suggests a parallel G4 formation and was only observed in the presence of K+ and MgCl2 (Figure 
35). The profile obtained at 95oC, in the presence of K+ and MgCl2 was consistent with that seen 





Figure 33 Amplicon of MEG3 region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 34 Sanger sequencing of MEG3 template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated G template. B) Template mixing of the methylated 
G template and the non-methylated A template. C) Template mixing of the two non-methylated 












Figure 35 CD spectra of MEG3 G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only.  
3.3.6.1   MEG3 (B) 
The second region from MEG3 was a 243 bp amplicon that contained a single G4 forming motif 
and was 54.7% GC with four CpG dinucleotides; one within the G4 motif (Table 3 and Figure 36). 
The variant template is represented by an adenine nucleotide and the wild-type template is 
represented by a guanine nucleotide (Figure 36). This MEG3 (B) region was initially difficult to 
amplify due to smeared PCR products; however, a small dilution and reaction volume 
adjustment resolved the smeared products (Appendix 4). When the methylated A template was 
mixed with the non-methylated G template prior to PCR, only the non-methylated G allele was 
visible during genotyping (Figure 37A). However, when the methylated G template was mixed 
with the non-methylated A template, the G allele was the major peak, and the A allele was a 
minor peak (Figure 37B). When the two non-methylated templates were mixed, both G and A 









































































































CD spectroscopy performed on the MEG3 (B) G4 motif demonstrated an elliptical profile 
consisting of a maximum at 260 nm and a minimum around 240 nm at 95oC (Figure 38). This 
profile suggests a parallel G4 structure and was only observed in the presence of K+ and MgCl2 
(Figure 38). The profile obtained at 95oC, in the presence of K+ and MgCl2 was consistent with 
that seen at 20oC (Appendix 5).  
 
Figure 36 Amplicon of MEG3 (B) region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 37 Sanger sequencing of MEG3 (B) template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated A template and non-methylated G template. B) Template mixing of the methylated 
G template and the non-methylated A template. C) Template mixing of the two non-methylated 












Figure 38 CD spectra of MEG3 (B) G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
MgCl2 and dashed line represents CD spectrum in 10 mM Tris-HCl only. 
3.3.7   PLAGL1 
The Homo sapiens pleiomorphic adenoma gene-like 1 (PLAGL1) gene is located on chromosome 
6 (Table 4). PLAGL1 is an imprinted gene that is expressed from the paternal allele in a range of 
fetal tissues including the brain and heart, however, bi-allelic expression has also been found in 
peripheral blood leucocytes (141). This gene is considered a tumour suppressor gene which 
encodes a zinc finger protein with DNA binding properties (124, 141). Like p53, this zinc finger 
protein has the ability to regulate apoptosis and cell cycle arrest (124, 141). Similar to other 
tumour suppressor genes, loss of expression of PLAGL1 dysregulates controlled cell growth, a 
condition observed in a range of cancers (141). Mutations in the genetic sequence can alter the 
tumour suppressor abilities of this protein. However, altered imprinting status of PLAGL1 that 
leads to overexpression of the paternal allele has been strongly associated with transient 
neonatal diabetes mellitus (TNDM) (124). Beckwith-Weidemann syndrome is another disorder 
caused by dysregulation of an imprinting region on chromosome 11 (ref 3.5.5) and interestingly 









































































































the imprinting locus on chromosome 11 and the TNDM imprinting locus on chromosome 6 
(125). Bliek et al. (2009) demonstrated that the subset of BWS patients have hypomethylation 
at a range of maternally methylated imprinting control regions, including that of PLAGL1 (125). 
This hypomethylation may therefore explain shared clinical phenotypes between BWS and 
TNDM (125), and also variations in the degree of disorder phenotypes.  
A 251 bp fragment that contained one G4 forming motif was selected for ADO analysis. This 
region was 50.2% GC and contained four CpG dinucleotides, none of which fall within the G4 
motif (Table 3 and Figure 39). Therefore, this region allows comparison of the degree to which 
location of CpG dinucleotides in relation to the G4 motif matters to ADO.  The wild-type 
template is represented by an adenine and the variant template is represented by a thymine 
(Figure 39). When the methylated T template was mixed with the non-methylated A template 
prior to PCR, only the non-methylated A allele was visible during genotyping (Figure 40A). 
Conversely, when the methylated A template was mixed with the non-methylated T template, 
only the T allele was visible (Figure 40B). When the two non-methylated templates were mixed, 
both A and T alleles were detected (Figure 40C).  
CD spectroscopy performed on the PLAGL1 G4 motif demonstrated an elliptical profile 
consisting of a maximum around 260 nm and a minimum near 240 nm at 95oC (Figure 41). This 
profile was suggestive of a parallel G4 and was only observed in the presence of K+ and MgCl2 
(Figure 41). The profile obtained at 95oC, in the presence of K+ and MgCl2 differed from 20
oC 
where a broad shoulder towards 290 nm was observed which is consistent with mixed species 
(Appendix 5).   
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Figure 39 Amplicon of PLAGL1 region.  
Wild-type primers are in green, variant primer (purple) introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 





Figure 40 Sanger sequencing of PLAGL1 template mixing experiments.  
Black box indicates the position of the single nucleotide variant. A) Template mixing of the 
methylated T template and non-methylated A template. B) Template mixing of the methylated 
A template and the non-methylated T template. C) Template mixing of the two non-methylated 












Figure 41 CD spectra of PLAGL1 G4 at 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Solid line represents the CD spectrum in the presence of 50 mM KCl and 1.5 mM 
























































































4  Discussion    
4.1   Summary of Findings 
The first aim of this thesis was to explore the general susceptibility to ADO of imprinted gene 
regions containing G4 structures. This required the development and application of an assay 
capable of detecting ADO events in PCR. A second aim was to explore whether the location of 
the methylation site, in relation to the G4 motif, influenced the occurrence of ADO. Summaries 
of the principal findings of this thesis are provided below and in Table 7 and Table 8.  
4.1.1  Allelic drop-out in Imprinted Genes 
ADO events caused by DNA methylation and G4 structure were only recently described, in a 
study from this laboratory that examined a region of the imprinted MEST gene (3). In order to 
test if this was a more global phenomenon within imprinted genes, a PCR assay was designed 
which detected ADO of methylated templates through Sanger sequencing. Prior to PCR, two 
templates that had different methylation states, and that differed by one nucleotide (referred 
to as an “artificial SNP”), were mixed together in order to mimic an imprinted locus in genomic 
DNA. By sequencing the PCR products from different template mixing experiments it was 
possible to detect ADO of one allele. Because both wild-type and variant templates were 
differentially methylated, the assay also demonstrated that ADO observed was not an artefact 
of the variant template. If this were to occur, it would be detected as a consistent drop-out of 
one allele, regardless of methylation status. 
The results described in this thesis confirm that methylation specific ADO is not unique to MEST 
and independently document the occurrence at nine additional gene loci. In eight of the genes, 
ADO was observed for both methylated wild-type and methylated variant alleles. MEG3 (B) 
demonstrated ADO of only one methylated allele. ADO was classed into two categories; 
complete ADO or partial ADO. “Complete ADO” was assigned when one allele was either absent 
entirely or barely visible in the Sanger sequencing trace. “Partial ADO” was classified when the 
second allele was still visible but was the minor peak in the Sanger sequencing output. 
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Two general rules emerged during this series of experiments. Whenever a control 
(unmethylated) template mixing reaction gave equivalent peaks for both alleles, complete ADO 
for the methylated allele was observed in the assay. Whenever a control template mixing gave 
unequal peaks for each allele, the major peak would show only partial ADO when methylated, 
while the minor peak would show complete ADO when methylated. This suggests that the 
observed partial ADO in these cases may be an artefact of differences in the input 
concentration of the two templates, an effect which was most pronounced when template 
dilutions were required to obtain a PCR product (as observed in DNMT1, MEG3 and MEG3 (B)). 
Although every effort was made to include equivalent amounts of each template in the assay, it 
is likely that there was some variability in quantification of templates. If one template was at a 
higher concentration, this template could be preferentially amplified during PCR and lead to 
reduced detection of the low concentration template, irrespective of the methylation status. 
This may account for why ADO in MEG3 could not be inferred (Table 7 and Figure 34), and is 
further discussed in Section 4.3.  
Overall, these results indicate that if the templates are equally represented in the template 
mixing assay, and both DNA methylation and G4 structure are present, then ADO of the 
methylated allele will ensue. This appears to be a consistent and reproducible phenomenon. 
This work has, therefore, demonstrated that G4 and methylation-specific ADO, previously 
observed in a MEST amplicon (3) is a more general phenomenon during PCR of many other 
imprinted regions of the genome. These data support the primary hypothesis made at the 
outset of this thesis (Section 1.7).  
4.1.2   Effect of Position of Methylation Sites with regard to the G-
quadruplex Motif 
Stevens et al. (2014) investigated a region within a CpG island on the maternally imprinted 
MEST isoform which contained three separate G4 forming motifs, all of which contained 
internal methylation sites. To test if the location of the methylated CpG is a factor that that 
impacts on ADO, amplicons used in this thesis were selected which contained either internal or 
external methylation, relative to the G4 motif. The amplicons from GRB10 and PLAGL1 (Sections 
3.3.4 and 3.3.7) did not contain any CpG dinucleotides within the predicted G4 motif.  GRB10 
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exhibited complete drop-out of the methylated variant allele and partial drop-out of the 
methylated wild-type allele, and PLAGL1 showed complete ADO in both methylated alleles 
(Figure 22 and Figure 30). This suggests that the G4 motif itself does not need to be methylated 
for ADO to occur, but rather the amplicon only needs to contain a methylated CpG. Therefore 
these data do not support the secondary hypothesis made at the outset of this thesis (Section 
1.7).  
The CpG in the GRB10 amplicon nearest to the G4 is 50 bp upstream of the motif, and for the 
PLAGL1 amplicon it is 6 bp downstream of the G4 motif (Figure 27 and Figure 39). These are in 
relatively close proximity to the G4 motif, and once the G4 structure has been adopted it is 
possible these methylation sites may somehow interact directly with the G4 structure. Because 
location of the methylated site within a G4 does not appear to be required for ADO, this 
extends the range of circumstances in which such events may occur. G4 motifs that lie within 
an imprinted gene may still be able to interact with methylated cytosines and contribute to 
ADO even if not directly located next to methylated DNA. This also opens up the possibility that 
these drop-out events might occur more widely when analysing genomic DNA by PCR. DNA 
methylation is not restricted to imprinted genes, and it is now clear that genomic DNA contains 
a great deal of cytosine methylation (142). It is expected that the same ADO events would be 
observed in PCR if these methylated regions in genomic DNA also harbour G4 forming motifs. 
4.1.3   In vitro G-quadruplex Structure Analysis 
This thesis investigated the occurrence of ADO during PCR of imprinted amplicons that 
contained both G4 structural motifs and DNA cytosine methylation. Computational algorithms 
were used to predict potential G4 forming motifs within the selected imprinted genes; 
however, it was necessary to confirm that these predicted motifs adopted the G4 structure in 
vitro during PCR. CD spectroscopy provides specific information on DNA structures by analysing 
the absorption of left-handed and right-handed polarised light as it passes through a chiral 
molecule (Section 1.1.3). As ADO is a phenomenon that occurs during PCR, CD was investigated 
at temperatures and ionic conditions representative of standard PCR.  In order to amplify DNA, 
the double stranded DNA molecule needs to be heat denatured which occurs at around 94oC 
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(69). Therefore, investigating CD of the G4 motifs at 95oC would confirm the ability of these 
structures to form and remain stable during PCR.  
CD spectroscopy revealed the presence of G4 structures in all amplicons that suffered ADO at 
95oC and confirmed that the parameters used to predict G4 motifs were adequate. Therefore, it 
is expected that these structures are able to form during PCR reactions and remain thermally 
stable. These structures were observed in the presence of potassium (which is required for G4 
formation), thus confirming that observed spectral profile is representative of G4 formation 
(143). The G4 conformations observed at this temperature were parallel, however, at 20oC 
antiparallel or mixed G4 species were observed (Appendix 5). This suggests that these other 
conformations within these G4 motifs are not thermally stable during PCR and therefore are 
not relevant to ADO. The G4 structures observed were expected, as potassium favours parallel 
G4 formation (143). In the absence of potassium, the G4 spectra were generally lost. However, 
the data does show that ions within the Tris – HCl buffer also induce G4 formation (Appendix 
5). The combined data from the template mixing assay and the confirmation of G4 structure 
using CD demonstrates that imprinted regions containing both DNA methylation and G4 
structure are likely to suffer from ADO and that this should be recognised as a more global 
phenomenon during PCR.  
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 Table 7 Summary of results found in template mixing assay.  
Gene CpG site in regards 




template mixing  
ADO observed* CD analysis Potential reason(s) for 
unexpected results 
AIM1 1 CpG at G4 motif 
boundary 
Template  G 
major peak 
Both methylated templates 
suffer complete ADO  
Parallel G4 stable 
at 95oC 
Data supports thesis hypotheses 
regardless of higher template  G 
input concentration 




Methylated template G suffers 
complete ADO and methylated 
template A becomes minor peak 
Parallel G4 stable 
at 95oC 
Template A at higher input 
concentration causing 
genotyping bias 
BLCAP (B) 1 CpG within G4 
motif 
Even Both methylated templates 
suffer complete ADO 
  
Parallel G4 stable 
at 95oC 
Data supports thesis hypotheses 
DNMT1 1 CpG at G4 motif 
boundary 





Methylated template  C  suffers 
complete ADO and methylated 
template A becomes minor peak 
Parallel G4 stable 
at 95oC 









Methylated template  C suffers 
complete ADO and methylated 
template A becomes minor peak 
Parallel G4 stable 
at 95oC 





*”Complete ADO” was categorised as either the complete absence of a peak for one allele, or when the peak was barely visible and would be classed as background noise. 
“Partial ADO” occurred when the methylated template was the minor peak observed. 
 
GRB10 No CpG within G4 Template G 
major peak 
Methylated template  A suffers 
complete ADO and methylated 
template G becomes minor peak 
Parallel G4 stable 
at 95oC 
Template G at higher input 
concentration causing 
genotyping bias and DNA 
methylation may interact with 
G4 from within amplicon 




Methylated template T suffers 
complete ADO and methylated 
template A becomes minor peak 
Parallel G4 stable 
at 95oC  
Template A at higher input 
concentration causing 
genotyping bias 




Both methylated and 
unmethylated template  A are 
barely visible and methylated 
and unmethyalted template  G is 
major peak 
Parallel G4 stable 
at 95oC 
Template G at higher input 
concentration causing 
genotyping bias 




Methylated template  A suffers 
complete ADO and methylated 
template  G remains major peak 
but at a decreased frequency 
Parallel G4 stable 
at 95oC 
Template G at higher input 
concentration causing 
genotyping bias 
PLAGL1 No CpG within G4 
motif 
Even Both methylated templates 
suffer complete ADO 
Parallel G4 stable 
at 95oC 
Data supports ADO thesis 
hypothesis and DNA methylation 




Table 8 Summary of regions unable to be analysed in template mixing assay  
Gene CpG site in regards to G4 motif Analysis difficulty Potential reason(s) for failure 
DLGAP2 2 CpG within G4 motif Sequencing data unable to be used Low PCR amplification during template mixing 
assay resulted in low quality DNA amplicons and 
often non-specific bands.  
GRB10 
(B) 




1 CpG at G4 motif boundary Amplification unsuccessful Unsuitable primers 
IGF2 3 CpG within G4 motif  
 1 CpG at G4 motif boundary 
Amplification unsuccessful Very GC rich sequence with multiple G4 motifs in 
both strands causing amplification failure 
LRRTM1 4 CpG within G4 motif Amplification unsuccessful Unsuitable primers 
MEG8 3 CpG within G4 motif 
1 CpG at G4 motif boundary 
Amplification unsuccessful Very GC rich sequence with multiple G4 motifs 
causing amplification failure 
NAA60 4 CpG within G4 motif  
1 CpG at the G4 motif boundary 
Amplification unsuccessful Very GC rich sequence with multiple G4 motifs 
causing amplification failure 
NPAP1 2 CpG within G4 motif Amplification unsuccessful Very GC rich sequence inhibiting amplification or 
unsuitable primers 
RB1 1 CpG within G4 motif Sequencing data unable to be used Inverted repeat within DNA amplicon underlying 
forward primer binding site resulting in 
sequencing in both directions 
RB1 (B) 3 CpG within G4 motif Amplification unsuccessful Unsuitable primers 
SLC22A3 2 CpG within G4 motif Sequencing data unable to be used and 
amplification failure during template mixing 
assay repeats 
Low PCR amplification during template mixing 
assay resulted in low quality DNA amplicons and 
often non-specific bands.  
ZDBF2 1 CpG within G4 motif 
1 CpG at G4 motif boundary 
Amplification unsuccessful Very GC rich sequence with multiple G4 motifs in 
both strands causing amplification failure 
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4.2  Implications of Results 
The objective of this work was to test if the observation of ADO described by Stevens et al. 
(2014) occurred in a variety of imprinted genes, rather than being unique to MEST. The 
detection of ADO in nine imprinted amplicons confirms that this mechanism of ADO is not only 
consistent but potentially quite widespread across the genome.  These data highlight the 
potential for unknown genotyping errors, which can have impact in a research setting, by 
falsely representing a homozygous genotype. The inability to correctly genotype can lead to 
inaccurate identification of a DNA sequence, which could affect decisions based on parental 
testing, genetic disease identification or screening, population based analyses and maintaining 
biodiversity in species at threat of extinction.  
The imprinted genes that were analysed in this thesis have been associated with a range of 
genetic disorders when altered imprinting status or mutations within these genes occur (Table 
4). Through the use of PGD, embryos that have a diseased genotype can be identified and not 
transferred to the mother (Section 1.5.1). Pregnancies at risk of DNMT1 related dementia, 
sensory neuropathy and deafness have been identified through this technique but this requires 
prior identification of the pathogenic variant in a family member (144). Neither of the selected 
regions from DNMT1 overlapped with this pathogenic mutation, nor did four additional G4 
motifs predicted in DNMT1 (26). However, one of these G4 motifs was found 1000 bp upstream 
of the mutational hotspot.  PGD has also been used successfully to avoid the genetic disorder 
retinoblastoma which can occur when the RB1 paternal mutated allele is expressed (145). ADO 
was not investigated at the RB1 region due to sequencing difficulties but the overall data 
suggests that ADO is likely to happen. The RB1 gene shows large mutational heterogeneity in 
retinoblastoma with over 900 identified mutations, most of which occur within the exonic 
regions (146, 147). The region selected for ADO analysis was intronic; therefore it is less likely 
to harbour mutations. An additional six potential G4 forming motifs were identified (26) within 
RB1, indicating that this gene may warrant further analysis of ADO events which have clinical 
relevance.  So while the specific regions studied here were not directly relevant to clinical 
diagnosis, these data do establish a principle that never the less may have important 
ramification for molecular diagnosis, in the context of imprinted genes. 
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4.3  Limitations  
This assay successfully demonstrated ADO at a variety of imprinted genes, however, limitations 
in assay design reduced the power for ADO detection. Amplification of five regions failed and 
this may have been due to the contribution of multiple G4 motifs (Table 8). The search 
parameters for G4 selection (Section 2.2) were successful in predicting highly stable motifs that 
adopted structure; however, these parameters may have failed to identify the formation of less 
stable G4 motifs (Table 8). Multiple G4 structures may reduce or prevent polymerase extension, 
leading to amplification failure.  
The difference in the degree of ADO observed between amplicons was considered likely to have 
resulted from unequal input concentrations of the two templates. The assay is dependent on 
the methods used to quantify DNA and where error arose at this stage, it may well have 
contributed to downstream problems in the assay.  A NanoDrop spectrophotometer (Bioline, 
Wilmington, DE, USA) was used to quantify DNA concentration; however, DNA degradation, 
and contamination proteins, salts, sugars and other molecules, can influence concentrations 
readings. To avoid such effects, quantitative PCR techniques could instead be used. 
Quantitative PCR or real-time PCR allows for the sensitive detection of a DNA sequence by using 
fluorescent technology, therefore the exact concentration of a sequence could be determined 
(148). The template mixing assay is a variation of a nested PCR design, in that a PCR product is 
re-amplified with the same primer pair. However, in 3 of the amplicons, this design was 
unsuccessful due to smeared PCR products. Redesigning the PCR primers to mirror that of a 
complete nested design could avoid the presence of these higher order smeared products. A 
nested PCR design is a two-step process which involves two primer pairs, one pair nested within 
the other and therefore increases the specificity of the PCR (149). This may avoid the presence 
of background DNA sequences getting re-amplified and therefore smeared PCR products.   
As mentioned in Section 4.1.1, unequal concentrations may bias the amplification of the 
abundant template during PCR regardless of methylation. Therefore, it was not possible to 
determine if the partial ADO was occurring as a result of methylation and G4, or from unequal 
DNA concentration. In MEG3, the difference in template concentration likely accounted for the 
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observation that the variant allele was barely detected during sequencing; regardless of 
methylation status (Figure 34). Therefore it was not possible to detect ADO in this region. A 
similar effect was seen in MEG3 (B), where ADO was not observed in the wild-type allele 
regardless of the methylation status. Additionally, DNMT1 and both amplicons from MEG3 
suffered from smeared products during the second round of PCR (Appendix 4). These smears 
contain large amounts of single stranded DNA and are thought to be the result of non-specific 
primer binding on DNA products amplified in earlier cycles (150). A second theory to the 
formation of smeared PCR products is the interaction of multiple G4s which form higher-order 
structures (151). However, this process is not understood and the data suggests that this 
artefact is concentration dependent (Appendix 4). Because the non-specific background DNA, 
which was not visible during the first round of PCR, would have been co-purified with the 
desired amplicons, these may have been re-amplified and resulted in smeared PCR products 
(150). PCR smearing was mitigated by performing a dilution series on the input DNA, prior to 
template mixing. However, diluting the DNA templates in this way appeared to exacerbate 
problems potentially caused by already unequal template concentrations, and lead to effective 
loss of one template from the assay reaction.  
A second limitation was quality and effectiveness of the HpaII and MspI methylation control. By 
using the two isoschizomers it is possible to differentiate between samples that contain 
methylated DNA by analysing DNA cleavage with gel electrophoresis (Appendix 3). However, 
visualisation of the cleavage was either not clear or completely failed in several samples 
(Appendix 3). This is because the resolution of the enzymatic cleavage is limited by not only the 
number of recognition sites but also incomplete DNA digestion (152). The methylation status of 
variant templates from MEG3, MEG3 (B) and AIM1 and the wild-type templates from BLCAP, 
DNMT1 (B) and AIM1 were inconclusive (Appendix 3). Because successful methylation was 
observed from the reactions performed in parallel, the methylation status was assumed to be 
consistent. As ADO was observed in AIM1, BLCAP and DNMT1 (B) it was concluded that these 
templates were appropriately methylated and that limitation in the visualisation of methylation 
controls were responsible for these discrepancies. Because the variant allele of MEG3 was 
barely visible during sequencing, ADO was unable to be detected and therefore the methylation 
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state could not be confirmed. Therefore, even if the concentration of the two templates of 
MEG3 were in balance with each other, ADO still may not have been observed in the variant 
allele due to inefficient methylation.  
Methyl binding domain proteins could be used as an alternative detection method that also 
quantifies the amount of methylation present. These proteins are able to bind to unrelated 
DNA sequences that are methylated (153) and this specificity has allowed them to be used in in 
vitro methylation detection assays (152). By attaching a tag to the methyl binding domain 
proteins, chemiluminescence can be detected and the intensity of each band analysed to give a 
semi-quantitative estimation of the overall DNA methylation within the sequence (152). This 
would then allow comparisons of ADO to be made between sequences that are rich in CpG 
dinucleotides and are therefore heavily methylated, with those that have a small number of 
methylation sites.  
4.4  Future Directions 
Although this thesis describes the observation of ADO in imprinted genes by DNA methylation 
and G4 structure in PCR, eight amplicons were unable to be amplified prior to template mixing 
assay and an additional four were unable to be analysed (Table 8). Several of these regions that 
failed to amplify were GC rich and also generally had two or more CpG dinucleotides within the 
G4 motif (Table 8). The difficult nature of amplifying GC rich sequences could account for these 
amplification failures. However, it is also possible that multiple G4 structures were forming in 
one or both strands during PCR and therefore essentially causing a “bi-allelic ADO” event. 
Designing an assay that would allow for the consistent amplification of these regions would 
confirm this phenomenon in PCR. For those regions that were not as GC rich, re-designing 
primers may aid in amplification. It would be of particular interest to analyse GRB10 (C) in the 
template mixing assay as this 292 bp region only contained one CpG dinucleotide. This would 
allow for the determination of the minimum amount of cytosine methylation required for these 
ADO events. The current working minimum analysed in this thesis was three CpG dinucleotides 
(AIM1, DNMT1 and GRB10) within the amplicon, and ADO was observed in all three regions. If 
DNA methylation at only one site is sufficient to mediate ADO, then it is likely that many regions 
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within the genome may be susceptible to such events, given that over 716,000 G4 motifs within 
the human genome have been detected (29).  
Collecting further data would allow for a more in-depth understanding of the widespread 
nature of ADO within imprinted genes during PCR. However, by examining other genomic 
regions that are not imprinted, but contain G4 motifs and substrates for methylation, the wider 
relevance of this mechanism to non-imprinted regions of the genome could be explored.  
Investigation of both the formation of G4 structure and methylation status of these G4 motifs in 
vivo could allow for the identification of hotspots within the genome where the DNA 
polymerase may stall, leading to ADO. In particular, further analysis of the GRB10 and PLAGL1 
amplicons may shed light on how DNA methylation that lies adjacent to the G4 motif 
contributes towards ADO events, either as an interactive or additive effect. Furthermore, using 
methyl binding domain proteins to quantify the in vitro methylation products would further 
improve the assay (Section 4.3). Generating a much wider set of data could contribute to 
development of a predictive model for sequences that are at risk of this form of ADO. In 
particular, such a model would allow for the characterisation of SNPs that are susceptible to 
ADO within the human genome. The application of such a predictive model could prove useful 
in both a diagnostic and research setting. Genetic sequences of interest could be analysed prior 
to PCR analysis and therefore either avoided or appropriately genotyped to circumvent 
inaccuracy.    
4.5  Conclusions 
This project involved the establishment of an assay capable of detecting DNA methylation and 
G4 structure mediated ADO in imprinted genes during in vitro amplification. Results obtained 
from nine imprinted genes confirm that this phenomenon is a global occurrence in the 
imprinted genome rather than being unique to the MEST gene. The data also indicated that the 
location of the methylated DNA in regards to the G4 motif is not strictly regulated and this 
suggests that ADO by this mechanism could affect more regions within the genome than 
previously anticipated. This thesis demonstrates the requirement for scepticism in PCR 
genotyping, especially when alleles appear to be out of Hardy-Weinberg equilibrium and the 
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necessity to not rely solely on genotyping data for genetic disease diagnostics. Further 
investigation into the mechanism by which the G4 motif interacts with both internal and 
external CpG dinucleotides would improve understanding of ADO and may advance the 
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Figures of amplicons that did not amplify or were unsuitable for 
analysis. 
Figure 1.1 Amplicon of DLGAP2 gene. 
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
Figure 1.2 Amplicon of GRB10 (B) gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
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Figure 1.3 Amplicon of GRB10 (C) gene. 
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
Figure 1.4 Amplicon of IGF2 gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
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Figure 1.5 Amplicon of LRRTM1 gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
Figure 1.6 Amplicon of MEG8 gene. 
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
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Figure 1.7 Amplicon of NAA60 gene. 
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
Figure 1.8 Amplicon of NPAP1 gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position. 
110 
 
Figure 1.9 Amplicon of RB1 gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
Figure 1.10 Amplicon of RB1 (B) gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
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Figure 1.11 Amplicon of SLC22A3 gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 
red. G4 motif represented in pink. Numbers indicate base pair position.  
Figure 1.12 Amplicon of ZDBF2 gene.  
Wild-type primers are in green, variant primer (purple) that introduces a SNP (yellow) into the 
sequence by site directed mutagenesis. HpaII/MspI cut sites are blue and CpG dinucleotides are 




Figures of gradient PCR gel electrophoresis visualisation 
 
 
Figure 2.1 Gradient PCR performed on the AIM1 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.2 Gradient PCR performed on the AIM1 gene using the primers which generated the 
variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 








Figure 2.3 Gradient PCR performed on the BLCAP gene. 
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.4 Gradient PCR performed on the BLCAP gene using the primers which generated the 
variant template. 
 Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.5 Gradient PCR performed on the BLCAP (B) gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 




Figure 2.6 Gradient PCR performed on the BLCAP (B) gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.7 Gradient PCR performed on the DLGAP2 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.8 Gradient PCR performed on the DLGAP2 gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 






Figure 2.9 Gradient PCR performed on the DNMT1 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.10 Gradient PCR performed on the DNMT1 gene using the primers which generated 
the variant template. 
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.11 Gradient PCR performed on the DNMT1 (B) gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.12 Gradient PCR performed on the DNMT1 (B) gene using the primers which 
generated the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.13 Gradient PCR performed on the GRB10 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.14 Gradient PCR performed on the GRB10 gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.15 Gradient PCR performed on the GRB10 (B) gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.16 Gradient PCR performed on the GRB10 (B) gene using the primers which 
generated the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.17 Gradient PCR performed on the GRB10 (C) gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.18 Gradient PCR performed on the IGF2 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.19 Gradient PCR performed on the KCNQ1 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.20 Gradient PCR performed on the KCNQ1 gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.21 Gradient PCR performed on the LRRTM1 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.22 Gradient PCR performed on the MEG3  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.23 Gradient PCR performed on the MEG3 gene using the primers which generated 
the variant template. 
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.24 Gradient PCR performed on the MEG3 (B) gene  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.25 Gradient PCR performed on the MEG3 (B) gene using the primers which generated 
the variant template. 
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.26 Gradient PCR performed on the MEG8 gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.27 Gradient PCR performed on the NAA60 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.28 Gradient PCR performed on the NPAP1.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.29 Gradient PCR performed on the PLAGL1 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.30 Gradient PCR performed on the PLAGL1 gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.31 Gradient PCR performed on the RB1 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.32 Gradient PCR performed on the RB1 gene using the primers which generated the 
variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.33 Gradient PCR performed on the RB1 (B) gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.34 Gradient PCR performed on the SLC22A3 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 
different annealing temperatures according to Section 2.4.3. 
 
Figure 2.35 Gradient PCR performed on the SLC22A3 gene using the primers which generated 
the variant template.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 





Figure 2.36 Gradient PCR performed on the ZDBF2 gene.  
Lane One is Kapa Universal Ladder and the following 12 lanes are reactions completed in 








Figures showing the HpaII/MspI restriction enzyme digest of 
methylated DNA. 
Both the location of the CCGG cut site and the number of sites within the amplicon varies per 
gene (Appendix 1) and therefore the difference in cleavage patterns also differ. A cut site that 
is at the beginning of the amplicon may not show a convincing difference between enzyme 
treatments, and those where multiple cut sites are present throughout the amplicon may be 
visualised as complete digestion. These less convincing methylation controls were still taken 
to be methylated due to differences observed in the final assay sequencing results (ref. 3.5) 
and the success of the remaining DNA samples confirmed a viable enzyme. 
 
Figure 3.1 HpaII/MspI methylated DNA digest of A) BLCAP B) BLCAP (B) C) BLCAP (B) SNP D) 
DNMT1 E) DNMT1 SNP. 
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 






Figure 3.2 HpaII/MspI methylated DNA digest of F) DNMT1 (B) G) DNMT1 (B) SNP H) GRB10.  
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 
and therefore move through the gel further.  
 
Figure 3.3 HpaII/MspI methylated DNA digest of I) KCNQ1 J) KCNQ1 SNP K) MEG3 L) MEG3 
SNP. 
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 









Figure 3.4 HpaII/MspI methylated DNA digest of M) GRB10 (B) N) GRB10 (B) SNP O) MEG3 (B) 
P) MEG3 (B) SNP. 
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 
and therefore move through the gel further.  
 
Figure 3.5 HpaII/MspI methylated DNA digest of Q) PLAGL1 R) PLAGL1 SNP S) DLGAP2 T) 
SLC22A3.  
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 






Figure 3.6 HpaII/MspI methylated DNA digest of U) GRB10 SNP V) AIM1 W) AIM1 SNP X) 
BLCAP SNP. 
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 
and therefore move through the gel further.  
 
Figure 3.7 HpaII/MspI methylated DNA digest of Y) DLGAP2 SNP Z) SLC22A3 SNP A1) RB1 B1) 
RB1 SNP. 
Lane One is Kapa Universal Ladder and the each sample is represented in two lanes, the first 
lane being HpaII and the second MspI. It is expected that MspI will cleave the methylated DNA 
and therefore move through the gel further.  
  






Figures of smeared PCR products. 
  
Figure 4.1 DNMT1 smeared PCR products 
Lane One is Kapa Universal ladder and the three following lanes are template mixing reactions. 
Smeared products were observed when PCR product was re-amplified. A 106 dilution resolved 
the smears so the DNMT1 224 bp region could be extracted. These smeared PCR products were 
also observed in potassium free buffer and are therefore not thought to be an artefact of G4 
formation.           
 
Figure 4.2 MEG3 smeared PCR products 
Lane One is Kapa Universal ladder and the three following lanes are template mixing reactions. 
Smeared products were observed when PCR product was re-amplified. A 106 dilution and PCR 
volumes of 10 µl resolved the smears so the MEG3 212 bp region could be extracted. These 
smeared PCR products were also observed in potassium free buffer and are therefore not 




Figure 4.3 MEG3 (B) smeared PCR products 
Lane One is Kapa Universal ladder and the three following lanes are template mixing reactions. 
Smeared products were observed when PCR product was re-amplified. Originally a 106 dilution 
and a 10µl PCR reaction volume was used to resolve the smeared products to the 243 bp band, 
however this resulted in the loss of the synthetic allele during sequencing. A 101 dilution was 
sequentially performed instead.  These smeared PCR products were also observed in potassium 




Figures of circular dichroism spectroscopy performed at 20oC and 
95oC. 
 
Figure 5.1 CD spectra of AIM1 G4 at 20oC and 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the absence of K+ an antiparallel G4 is observed 

























































































Figure 5.2 CD spectra of BLCAP G4 at 20oC and 95oC.  
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC in the absence of K+ a parallel G4 is still detected, 


























































































Figure 5.3 CD spectra of BLCAP (B) G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the absence of K+, mixed species are observed but 
it not thermally stable. This indicates that ions within the Tris – HCl PCR buffer contribute to G4 

























































































Figure 5.4 CD spectra of DNMT1 G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC there is a broad shoulder to 290 nm which indicates the 

























































































Figure 5.5 CD spectra of DNMT1 (B) G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the presence of K+, a parallel G4 is observed and 
























































































Figure 5.6 CD spectra of GRB10 G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the absence of K+, mixed species are observed but 
it not thermally stable. This indicates that ions within the Tris – HCl PCR buffer contribute to G4 


























































































Figure 5.7 CD spectra of KCNQ1 G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the presence of K+, mixed species are observed 
but the parallel conformation is the most stable at higher temperature. In the absence of K+ the 
parallel signature is lost, and an antiparallel conformation remains. This indicates that ions 



























































































Figure 5.8 CD spectra of MEG3 G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the presence of K+, a parallel conformation is 

























































































Figure 5.9 CD spectra of MEG3 (B) G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the absence of K+, a parallel G4 conformation is 










































































































Figure 5.10 CD spectra of PLAGL1 G4 at 20oC and 95oC. 
Molar ellipticity (x105 deg.cm2.dmol-1) is on the vertical axis and wavelength (nm) is on the 
horizontal axis. Black lines represent CD at 95oC and grey lines at 20oC. Solid lines represent the 
CD spectra in the presence of 50 mM KCL and 1.5 mM MgCl2 and the dashed lines represent CD 
spectra in 10 mM Tris-HCl only. At 20oC and in the presence of K+, a broad shoulder to 290 nm 
indicates the presence of mixed species in solution, although these are not thermally stable. 
Antiparallel conformation was also observed in the absence of K+ which indicates that ions 
within the Tris – HCl PCR buffer contribute to G4 formation.   
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